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ABSTRACT	  	  	  	  ADHD	  is	  a	  childhood	  neurobehavioral	  disorder	  characterized	  by	  inordinate	  levels	  of	  hyperactivity,	  inattention	  and	  impulsivity.	  The	  inability	  to	  withhold	  a	  reinforced	  response,	  or	  response	  inhibition	  capacity	  (RIC),	  is	  one	  aspect	  of	  impulsivity	  associated	  with	  ADHD.	  The	  first	  goal	  of	  this	  dissertation	  was	  to	  evaluate	  the	  fixed	  minimum	  interval	  (FMI)	  schedule	  as	  a	  method	  for	  assessing	  RIC.	  Chapter	  2	  showed	  that	  latencies	  were	  substantially	  more	  sensitive	  than	  FMI-­‐derived	  estimates	  of	  RIC	  to	  the	  effects	  of	  pre-­‐feeding	  and	  changes	  in	  rate	  and	  magnitude	  of	  reinforcement.	  Chapter	  3	  examined	  the	  ability	  of	  the	  FMI	  to	  discriminate	  between	  spontaneously	  hypertensive	  rats	  (SHR),	  an	  animal	  model	  of	  ADHD,	  and	  Wistar	  Kyoto	  (WKY)	  controls.	  Results	  from	  Chapter	  3	  showed	  that	  RIC	  was	  not	  substantially	  different	  between	  SHR	  and	  WKY	  rats.	  However,	  latencies	  were	  significantly	  shorter	  for	  SHRs	  than	  for	  WKYs	  suggesting	  incentive	  motivation	  differed	  between	  strains.	  The	  second	  goal	  of	  this	  dissertation	  was	  to	  examine	  the	  sensitivity	  of	  the	  SHR	  to	  nicotine.	  ADHD	  is	  a	  risk	  factor	  for	  tobacco	  dependence.	  The	  goal	  of	  Chapters	  4	  and	  5	  was	  to	  determine	  whether	  the	  SHR	  provided	  a	  model	  of	  ADHD-­‐related	  tobacco	  sensitivity.	  Chapter	  4	  examined	  nicotine's	  locomotor	  and	  rewarding	  effects	  in	  adolescent	  SHRs	  using	  the	  conditioned	  place	  preference	  (CPP)	  procedure.	  SHRs	  developed	  CPP	  to	  the	  highest	  nicotine	  dose	  tested	  and	  were	  sensitive	  to	  nicotine's	  locomotor-­‐enhancing	  properties.	  WKY	  controls	  did	  not	  develop	  CPP	  to	  any	  nicotine	  dose	  tested	  and	  were	  not	  sensitive	  to	  nicotine's	  locomotor	  properties.	  However,	  it	  is	  likely	  that	  nicotine	  effects	  were	  obscured	  by	  a	  pseudo-­‐conditioning	  to	  saline	  in	  WKYs.	  Chapter	  5	  demonstrated	  that	  SHRs	  were	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more	  active	  than	  WKYs	  in	  the	  open-­‐field	  but	  not	  in	  the	  Rotorat	  apparatus.	  Results	  also	  showed	  that	  SHRs	  and	  WKYs	  were	  both	  sensitive	  to	  nicotine's	  locomotor	  sensitizing	  effects.	  However,	  WKYs	  were	  more	  sensitive	  than	  SHRs	  to	  nicotine's	  locomotor	  suppressing	  effects.	  Collectively,	  results	  from	  Chapters	  4	  and	  5	  show	  that	  SHRs	  are	  sensitive	  to	  the	  rewarding	  and	  locomotor-­‐enhancing	  properties	  of	  nicotine.	  However,	  more	  research	  is	  necessary	  to	  confirm	  that	  SHRs	  are	  a	  suitable	  model	  for	  studying	  ADHD-­‐related	  tobacco	  use.	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CHAPTER	  1	  GENERAL	  INTRODUCTION	  
ADHD is a childhood neurobehavioral disorder characterized by inordinate levels of 
hyperactivity, inattention and impulsivity (American Psychiatric Association, 2013) and has been 
shown to be a risk factor for tobacco dependence (Kollins, McClernon, & Fuemmeler, 2005; 
McClernon & Kollins, 2008). The number of ADHD symptoms is negatively associated with the 
age of initial tobacco use and positively associated with the number of cigarettes consumed daily 
(Kollins et al., 2005).  However, individual symptoms, even when below clinical thresholds, are 
associated with an increased risk of tobacco use (Kollins et al., 2005a).  
The prevalence of smoking among adolescents and adults with ADHD is nearly double 
that of their non-diagnosed peers (Breyer, Lee, Winters, August, & Realmuto, 2014; Lambert & 
Hartsough, 1998; Milberger, Biederman, Faraone, Chen, & Jones, 1997; Molina & Pelham Jr., 
2003). Furthermore, adolescents with ADHD report first experimenting with tobacco and 
progressing to regular use at a younger age (Kollins et al., 2005; Milberger et al., 1997), 
consume greater amounts of tobacco (Kollins et al., 2005), are more likely to become tobacco 
dependent (Kollins et al., 2005) and more likely to continue smoking into adulthood (Breyer et 
al., 2014; Chang, Lichtenstein, & Larsson, 2012; Kollins et al., 2005; Lambert & Hartsough, 
1998). Once dependent, individuals with ADHD have greater difficulty quitting and exhibit more 
severe withdrawal symptoms than non-ADHD smokers (Kollins et al., 2005; Lasser, 2000). The 
severity of abstinence-induced withdrawal symptoms appears to be directly related to higher 
relapse rates and higher rates of tobacco dependence among ADHD smokers (Lasser, 2000; 
McClernon & Kollins, 2008).  
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Differences in the subjective experience of smoking and factors contributing to the 
motivation to smoke differ between smokers with and without ADHD (Mitchell, McIntyre, 
McClernon, & Kollins, 2014; Van Voorhees et al., 2012). Specifically, smokers with ADHD 
report that smoking is more calming, provides greater positive and negative reinforcement and 
cognitive enhancement. Transdermal nicotine reduces self-reported ratings of ADHD symptoms 
measured with the Clinical Global Impressions Scale (Levin et al., 1996; Levin, Conners, Silva, 
Canu, & March, 2001) and the Conners Parent Rating Scale (Shytle, Silver, Wilkinson, & 
Sanberg, 2009). Smokers with ADHD report greater satisfaction and liking of puffs (Van 
Voorhees et al., 2012). Smoking related cues appear to acquire greater significance in ADHD 
smokers, who report experiencing them more frequently (Mitchell et al., 2014).  
Human studies provide a framework for assessing the magnitude of the ADHD-tobacco 
link, but understanding the neural and behavioral mechanisms relies on the use of an animal 
model. The identification of an animal model that exhibits behavioral, genetic and 
neurobiological abnormalities similar to humans with ADHD would greatly facilitate research in 
the area of ADHD-related tobacco use. Such a model would allow for the examination of how 
nicotine, the primary psychoactive component of tobacco, affects behavior and the underlying 
neurobiology (Benowitz, 1999; Stolerman & Jarvis, 1995). One of the overarching goals of the 
studies included in this dissertation is to assess the suitability of one of the most validated animal 
models of ADHD, the spontaneously hypertensive rat (SHR) (Sagvolden, 2000), as a model of 
ADHD-related tobacco use. The SHR exhibits similar genetic and neurobiological abnormalities 
observed in humans with ADHD. For example, like individuals with ADHD (Faraone & Khan, 
2006; Krause, Dresel, Krause, Kung, & Tatsch, 2000; Solanto, 2002), SHRs have dopamine 
transporter (DAT) genetic abnormalities (Russell, Sagvolden, & Johansen, 2005), decreased 
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hippocampus and prefrontal cortex volume (Russell et al., 2005), and abnormalities in dopamine 
metabolism and functioning (Russell, 2002, 2003; Russell, Villiers, Sagvolden, Lamm, & 
Taljaard, 1998). The SHR also exhibits core behavioral symptoms of ADHD such as impulsivity 
(Sanabria & Killeen, 2008; Thanos et al., 2010), inattention (Jentsch, 2005), and hyperactivity 
(Hill, Herbst, & Sanabria, 2012; Hsieh & Yang, 2008), some of which are alleviated by 
methylphenidate (Myers, Musty, & Hendley, 1982; Sagvolden & Johansen, 2012; Wigestrand et 
al., 2011). The SHR is responsive to nicotine (Davids, Zhang, Tarazi, & Baldessarini, 2003; 
Wigestrand et al., 2011) and has fewer nicotinic acetylcholine receptors (nAChR) in multiple 
brain regions (Gattu, Pauly, Boss, Summers, & Buccafusco, 1997; Hohnadel, Hernandez, 
Gearhart, & Terry, 2005; Terry, 2000), a pattern similar to that of individuals with ADHD 
(Wigestrand et al., 2011). nAChR irregularities contribute to symptoms of ADHD (Ueno, 2002) 
and nicotine-induced stimulation of nAChRs underlies both tobacco-related reward and 
dependence (Dwoskin & Bardo, 2009), as well as nicotine-driven improvements in ADHD-
related symptoms (Lloyd & Williams, 2000). Nicotine reward and nicotine-induced ADHD 
symptom alleviation is largely due to nAChR regulation of dopamine (DA) activity in the 
mesocorticolimbic system (Dani & Harris, 2005; Potter & Newhouse, 2004). Specifically, 
nicotine increases the firing rates and phasic bursting of DA neurons in the ventral tegmental 
area (VTA), which enhances the release of dopamine into the nucleus accumbens (NAc) (Besson 
et al., 2007).  Individuals with ADHD have low tonic DA levels which give rise to nicotine-
induced exaggerated phasic burst activity (McClernon & Kollins, 2008). It is believed that 
exaggerated phasic DA burst activity underlies heightened sensitivity to smoking-related rewards 
in individuals with ADHD (McClernon & Kollins, 2008). Indeed, ADHD smokers describe 
smoking as more satisfying and pleasurable than non-ADHD smokers (Van Voorhees et al., 
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2012). Dopaminergic projections from the VTA to the NAc and mPFC have also been implicated 
in nicotine-related relief of ADHD symptoms (Potter, Newhouse, & Bucci, 2006; Potter & 
Newhouse, 2004). It is believed that nicotine acts like a stimulant to normalize hypofunctioning 
DA activity along these pathways (Potter et al., 2006; Potter & Newhouse, 2004; Sagvolden, 
2000).  
The SHR provides a promising candidate model for studying ADHD-related tobacco use.  
The SHR can be used to examine smoking-induced improvements in ADHD symptoms by 
measuring how nicotine impacts performance on validated behavioral tasks.    
ADHD-associated response inhibition deficits 
ADHD is a complex and highly heterogenous disorder (Fair, Bathula, Nikolas, & Nigg, 
2012; Steinhausen, 2009). This heterogeneity is reflected in the clinical manifestation of the 
disorder as well as underlying genetic and neuropsychological causes combined (American 
Psychiatric Association, 2013; Fair et al., 2012; Nigg, Willcutt, Doyle, & Sonuga-Barke, 2005; 
Steinhausen, 2009).  
Impulsivity is one of the defining characteristics of ADHD and refers to a spectrum of 
behaviors that can be described as “poorly conceived, prematurely expressed, unduly risky, or 
inappropriate to the situation and that often result in undesirable outcomes” (Daruna & Barnes, 
1993). It refers to not just one type of behavior, but multiple behaviors with potentially distinct 
biological underpinnings (Evenden, 1999; Winstanley, Eagle, & Robbins, 2006).  The inability 
to withhold a reinforced response, or response inhibition capacity (RIC), is one aspect of 
impulsivity that has been proposed to be the core deficit of ADHD (Barkley, 1997; Bellgrove, 
Hawi, Kirley, Gill, & Robertson, 2005; Wodka et al., 2007). There are a variety of tasks 
designed to measure RIC in clinical and preclinical populations.  Of these, we will focus on those 
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that are designed to measure one aspect of RIC referred to as “waiting” impulsivity, which is 
conceptualized as the ability to inhibit or delay prepotent responses in order to obtain 
reinforcement (Dalley, Everitt, & Robbins, 2011; Jentsch et al., 2014).  
The Continuous Performance Task (CPT) 
 The Continuous Performance Task (CPT) was designed to measure sustained and divided 
attention in humans (Rosvold, Mirsky, Sarason, Bransome, & Beck, 1956). More recently it has 
been suggested that aspects of CPT performance reflect the ability to inhibit prepotent responses 
(Robbins, 2002) and, therefore, the CPT has also been used for the purpose of assessing RIC 
(Robbins, 2002). Although there are a number of different versions of the CPT, the general 
procedure involves rapidly presenting stimuli that are visually and/or temporally unpredictable. 
Participants are instructed to respond only to specific stimuli (“Go” stimuli) and withhold 
responding to all other stimuli (“No-Go” stimuli) (Rosvold et al., 1956). Attention is generally 
inferred from mean reaction times, the variability in response times, and the number of omitted 
responses to the “Go” stimuli (i.e., omission errors) (Bekker, Böcker, Van Hunsel, van den Berg, 
& Kenemans, 2005). The number of incorrect responses made to “No-Go” cues (i.e., “false 
alarms”) is believed to reflect inhibitory deficits (Bekker et al., 2005; Castellanos & Tannock, 
2002).  
 The 5-choice serial reaction-time task (5CSRTT) is the preclinical analogue to the CPT 
(Robbins, 2002). In the 5CSRTT subjects are presented with repeated trials in which a visual 
stimulus is briefly presented in one of five apertures.  Subjects are required to respond 
(nosepoke) to the aperture corresponding to the visual stimulus. Correct responses are reinforced 
and incorrect responses are typically punished. Trials are separated by an inter-trial interval 
(ITI). Premature responses made during the ITI are an index of deficient response inhibition and 
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are believed to be analogous to CPT false alarms (Robbins, 2002). The percentage of correct or 
accurate responses, and the number of omitted responses are believed to reflect attention 
(Robbins, 2002; Dommett, 2014). Preclinical studies have shown that the 5CSRTT does not 
discriminate between the SHR and controls (van den Bergh et al., 2006). In fact, SHRs have been 
shown to be less impulsive than controls on the 5CSRTT and are also unresponsive to 
methylphenidate (van den Bergh et al., 2006).   
Differential Reinforcement of Low Rate (DRL) schedule of reinforcement 
The differential reinforcement of low rate (DRL) schedule (Skinner, 1938) is another task 
used to measure the ability to inhibit or delay prepotent responses in both humans and non-
human animals (Bardo, Cain, & Bylica, 2006; Gordon, 1979; McClure & Gordon, 1984; Orduña, 
Valencia-Torres, & Bouzas, 2009; Solanto, 1990). In the DRL schedule, an operant response is 
reinforced if it is separated from the preceding response by an interval of a fixed minimum 
duration. Responses made prematurely are not reinforced, but rather reset the clock that 
programs reinforcement. Children with ADHD have greater difficulty inhibiting premature 
responses on the DRL schedule (Dickerson, Mayes, Calhoun, & Crowell, 2001; M. Gordon, 
1979; Mancebo, 2002; McClure & Gordon, 1984) and have lower efficiency ratios (the number 
of reinforced responses divided by the total number of responses) than children without ADHD 
(Dickerson et al., 2001). Preclinical studies have shown that the SHR is also deficient on the 
DRL (Ferguson et al., 2007b; Orduña et al., 2009; Sanabria & Killeen, 2008a; van den Bergh et 
al., 2006).  Clinical findings regarding the ability of the DRL to differentiate between individuals 
with and without ADHD suggests a high degree of discriminant validity (Gordon, 1979; 
Mancebo, 2002; McClure & Gordon, 1984; Solanto, 1990). However, ADHD stimulant 
medications such as methylphenidate and d-amphetamine, which reduce clinical symptoms of 
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impulsivity in humans (Sunohara et al., 1999) have been shown to either impair (Emmett-
Oglesby, Taylor, & Dafter, 1980; Ferguson et al., 2007a; Seiden, Andresen, & MacPhail, 1979) 
or have no significant effect (Andrzejewski et al., 2014; van den Bergh et al., 2006) on DRL 
performance in non-human animals.  
The DRL and 5CSRTT are also limited by the degree to which incentive motivation and 
response requirement can impact measures of RIC. Changes to the level of motivation brought 
on by variations in weight restriction and pre-session feeding increase ITI responding in the 
5CSRTT (Bizarro & Stolerman, 2003). In the DRL, changes to the magnitude of the reinforcer 
(Beer & Trumble, 1965; Doughty & Richards, 2002; Kirshenbaum, Brown, Hughes, & Doughty, 
2008), response effort (Topping, Pickering, & Jackson, 1971) and level of deprivation (Conrad, 
Sidman, & Herrnstein, 1958; Holz & Azrin, 1963; Tanno, Kurashima, & Watanabe, 2011) affect 
DRL performance.  
Fixed Minimum Interval (FMI) schedule of reinforcement 
The fixed minimum interval (FMI) schedule of reinforcement (Mechner & Guevrekian, 
1962) is a modification of the DRL schedule. Mechner and Guevrekian (1962) developed and 
tested a forerunner of the procedure implemented in the studies presented here. In Mechner and 
Guevrekian’s FMI, rats initiated an inter-response time (IRT) by pressing one lever and 
terminated it by pressing another lever; it is unclear from their description whether or not 
consecutive responses on the IRT-initiating lever restarted the clock that programmed 
reinforcement. Mechner and Guevrekian demonstrated that, in FMI, deprivation of the reinforcer 
primarily affects the latency to the IRT-initiating response and not the distribution of IRTs. 
These findings suggest that distinct features of FMI performance are differentially sensitive to 
changes in response strength and (potentially) to changes in RIC. This dissociation has motivated 
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the use of variations of FMI in subsequent studies on behavioral regulation (Hill, Covarrubias, 
Terry, & Sanabria, 2012; Mazur, Wood-Isenberg, Watterson, & Sanabria, 2014; Mika et al., 
2012; Soffié & Lejeune, 1991). Further support for the FMI has come from recent findings in our 
laboratory that methylphenidate enhances an FMI-derived index of RIC (Hill, Covarrubias, et al., 
2012) and that chronic stress diminishes it (Mika et al., 2012).  
RIC, ADHD and substance abuse 
RIC, and impulsivity more generally, are related to several phases of drug abuse such as 
initiation, escalation of intake, dependence and reinstatement following relapse (Carroll, Anker, 
& Perry, 2009).  Preclinical studies are particularly useful for studying the relationship between 
RIC and phases of the addiction cycle. Rats identified as having poor RIC in the 5CSRTT show 
enhanced acquisition and maintenance of nicotine (Diergaarde et al., 2008) and cocaine (Dalley 
et al., 2007) self-administration. Impaired RIC is also associated with greater escalation and 
resistance to punishment in cocaine self-administration studies (Belin, Mar, Dalley, Robbins, & 
Everitt, 2008; Dalley et al., 2007). Thus, RIC is a predictor of different phases of the addiction 
cycle. The SHR, which models several aspects of ADHD, including RIC deficits (Orduña et al., 
2009; Sanabria & Killeen, 2008a; van den Bergh et al., 2006), has also been used to study the 
relationship between ADHD and substance abuse (Chen, Hiler, Tolley, Matta, & Sharp, 2012; 
Mazur et al., 2014). The SHR exhibits greater sensitivity to several classes of drugs 
(Vendruscolo, Izídio, & Takahashi, 2009) including alcohol (Da Silva, Vendruscolo, & 
Takahashi, 2005), stimulants (dela Peña et al., 2011; Harvey, Sen, Deaciuc, Dwoskin, & Kantak, 
2011), cannabinoids (Vendruscolo et al., 2009) and opioids (Bhargava & Gulati, 1988).  
There is a surprising dearth of research on the behavioral effects of nicotine in the SHR. 
To our knowledge only one study has attempted to examine whether SHRs are more sensitive to 
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nicotine than controls (Chen et al., 2012). This study provided the first evidence that SHRs 
respond more for nicotine reinforcement than 10 other rat strains.  Although reinforcement 
processes are important in the initiation and maintenance of smoking behavior, other factors also 
contribute to tobacco abuse and dependence in humans, such as associative learning processes, 
the sensitivity to the initial positive and/or negative effects of tobacco, the development of 
tolerance to these effects, and the severity of withdrawal symptoms. Additional research is 
needed to examine how nicotine affects these processes in animal models through the use of 
paradigms such as conditioned place preference (CPP), intracranial self-stimulation (ICSS) and 
locomotor sensitization.  
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CHAPTER	  2	  VALIDATION	  OF	  THE	  FIXED	  MINIMUM	  INTERVAL	  SCHEDULE	  AS	  A	  METHOD	  TO	  MEASURE	  RESPONSE	  INHIBITION	  CAPACITY	  IN	  RATS	  
Attention Deficit Hyperactivity Disorder (ADHD) is one of the most prevalent 
psychiatric disorders, affecting approximately 5.29% of the population worldwide (Polanczyk, 
Willcutt, Salum, Kieling, & Rohde, 2014). ADHD is characterized by elevated and persistent 
levels of inattention, locomotor activity, and impulsivity (American Psychiatric Association, 
2013). The construct of impulsivity encompasses a wide range of phenomena (Evenden, 1999; 
Winstanley et al., 2006). One variety of impulsivity associated with ADHD is often described as 
a deficit in “behavioral inhibition” (Barkley, 1997; Wodka et al., 2007) and “response inhibition 
capacity” (RIC; Chambers, Garavan, & Bellgrove, 2009). RIC, which is the focus of this paper, 
is the relatively stable ability to withhold an instrumentally reinforced response (e.g., 
withholding playing behavior in the classroom, or refusing an available but forbidden treat). 
Research on the neurobiological substrate of RIC is greatly aided by animal models of 
ADHD, and by validated procedures to assess RIC in these models. Various genetic and lesion 
models of ADHD have been proposed (Russell, 2011), with most attention focused on the 
spontaneously hypertensive rat (SHR; Russell, Sagvolden, & Johansen, 2005; Sagvolden et al., 
1992; Miller, Pomerleau, Huettl, Russell, Gerhardt & Glaser, 2012; Russell, 2002, 2003; Russell, 
Allie & Wiggins, 2000). Also, various methods for assessing RIC have been proposed, including 
the 5-choice serial reaction time task (5-CSRTT; e.g.,(Robinson et al., 2009), and the differential 
reinforcement of low rates schedule (DRL; e.g., (Stewart et al., 2006).  
Although there is no published systematic review of RIC tasks, a succinct review shows 
various limitations and information gaps regarding their validity as methods to assess RIC. In 
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particular, many of these tasks do not provide RIC indices that respond appropriately to key 
pharmacological treatments and that are robust against confounding factors, such as motivation. 
Moreover, there is no published information on the reliability of these indices. The purpose of 
this paper is to examine a RIC task that appears to address the limitations of extant methods, the 
fixed minimum interval schedule (FMI; (Mechner & Guevrekian, 1962).  
Pharmacological treatments that enhance RIC in humans do not reliably elevate RIC 
indices in 5-CSRTT (Bizarro, Patel, Murtagh, & Stolerman, 2004; Navarra et al., 2008) and 
systematically lower them in DRL (Andrzejewski et al., 2014; Emmett-Oglesby et al., 1980; 
Ferguson et al., 2007b; Meaux & Chelonis, 2003; Seiden et al., 1979). These findings suggest a 
reduced sensitivity of the 5-CSRTT and the DRL tasks to RIC-enhancing drug treatments. In 
contrast, RIC indices drawn from the FMI tasks are elevated by appropriate pharmacological 
treatments (Hill, Covarrubias, et al., 2012).  
Moreover, changes in motivation appear to influence RIC indices in 5-CSRTT (Bizarro 
& Stolerman, 2003) and in DRL (Conrad et al., 1958; Doughty & Richards, 2002; Kirshenbaum 
et al., 2008). These findings suggest a reduced specificity of the 5-CSRTT and the DRL tasks to 
changes in RIC. In contrast, RIC indices drawn from the FMI tasks appear to be robust against 
changes in motivation (Mazur et al., 2014; Mechner & Guevrekian, 1962).  
The FMI task appears to be the best candidate RIC task from those currently available. 
The present study focuses on validating the FMI task. In procedural terms, the FMI involves only 
a small modification of the DRL task: in FMI the response that initiates the withholding interval 
is different from the one that terminates it, whereas in DRL they are the same. This similarity is 
important because DRL performance has been extensively studied in humans and animals 
(Dickerson et al., 2001;  Gordon, 1979; Sanabria & Killeen, 2008; Stein & Flanagan, 1974), and 
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in humans it is associated with ADHD-related impulsivity (Dickerson et al., 2001;  Gordon, 
1979).  
The FMI task was examined in two experiments. Experiment 1 tested whether the FMI-
derived index of RIC is sensitive to the withholding requirement, and is robust against a pre-
feeding manipulation. Experiment 2 further evaluated the reliability of the FMI task, and 
extended the test of its robustness against changes in motivation to two other manipulations: 
changing the rate of reinforcement and changing the magnitude of reinforcement. It was 
predicted that estimates of RIC derived from the FMI would be robust against pre-feeding and 
changes to reinforcement rate and magnitude.  
Experiment 1 
Method 
Subjects 
Ten experimentally-naïve male Sprague Dawley rats (Charles River, Hollister, 
California). Rats arrived on post-natal day (PND) 60 and were immediately pair-housed in a 
colony room with a 12:12-h day:night cycle, with lights on at 1900 h. Upon arrival food was 
available ad libitum in the homecage, but was gradually reduced to 1 hr daily access provided in 
the afternoon, a minimum of 20.5 h before the scheduled experiment on the following day. Water 
was always available ad libitum in the homecage. Each homecage contained two nylon bones 
(Bio-Serv model # K3580) that were replaced weekly.  All experimental protocols were 
conducted in accordance with the guidelines provided by the National Institutes of Health and 
approved by the Arizona State University Institutional Animal Care and Use Committee.  
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Apparatus 
Experiments were conducted in 10 MED Associates (St. Albans, VT) modular test 
chambers (3 were 305 mm long, 241 mm wide, and 210 mm high; 7 were 305 mm long, 241 mm 
wide, and 292 mm high), each enclosed in a sound- and light-attenuating box equipped with a 
ventilation fan. The front and back walls and the ceiling of the test chambers were made of 
Plexiglas; the front wall was hinged and served as a door to the chamber. One of the two 
aluminum side panels served as a test panel. The floor consisted of 5-mm steel rods spaced 16 
mm apart and positioned 36 mm above a catch pan. A square opening (51 mm each side) located 
15 mm above the floor and centered on the test panel provided access to a food hopper (MED 
Associates, ENV-200-R2M). One 45-mg sucrose pellet (Test Diet, Richmond, IN) was delivered 
to the hopper with each activation of the dispenser. A multiple tone generator (MED Associates, 
ENV-223) was used to produce 3 kHz tones at approximately 75 dB through a speaker (MED 
Associates, ENV-224AM) centered on the top of the wall opposite to the test panel. Two 
retractable levers (ENV-112CM) were located on either side of the food hopper, but only one—
the one closest to the door—was operational. Three-color light stimuli (ENV-222M) were 
mounted 35 mm above each lever; they could be illuminated yellow, green, and red. A force of 
approximately 0.2 N applied to the end of the lever was necessary for a lever press to be 
recorded. The ventilation fan mounted on the rear wall of the sound-attenuating chamber 
provided masked noise of approximately 60 dB. Experimental events were arranged via a Med-
PC® interface connected to a PC controlled by Med-PC IV® software. 
Procedure 
 Sessions were conducted daily, 7 days per week. Training started with one session of 
chamber habituation followed by one to two sessions of hopper training during which sucrose 
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pellets were presented on a variable-time 15-s schedule. Once all rats were reliably eating all 
sucrose pellets, lever pressing for sucrose pellets was hand-shaped. After all rats were reliably 
lever pressing for sucrose pellets FMI sessions began.  
In this task, subjects initiated each inter-response time (IRT) with a lever press (initial 
response), and were then required to withhold a head entry response into the hopper (terminal 
response) for a criterial time (t) for reinforcement to occur. An IRT was considered correct if it 
was equal or greater to the criterial time t, and incorrect if it was shorter than criterial time t. 
Correct IRTs were followed by an auditory cue, the retraction of the lever, and reinforcement 
arranged according to a conjunctive variable-interval (VI) schedule (see below). All trials were 
separated by a 10-s ITI. 
 Conjunctive VI schedule 
During FMI testing, reinforcement was arranged on a VI schedule to reduce changes in 
reinforcement rates due to schedule and performance (Kirshenbaum et al., 2011; Sagvolden & 
Berger, 1996). At the beginning of a given session and after each reinforcer, an interval was 
selected without replacement from a 12-item Fleschler-Hoffman list (Fleshler & Hoffman, 
1962). A stopwatch ran throughout the session; when it reached the randomly selected interval, 
reinforcement was programmed for the next correct IRT. If the interval elapsed within an IRT, 
that IRT was not reinforced; instead, reinforcement was set up for the next correct IRT.  
The conjunctive VI schedule was introduced upon reliable performance in the first FMI 
condition (FMI 0.5-s). The VI schedule increased progressively over the course of multiple 
sessions from VI 9-s to 15, 30, 60 and 90-s. Progression was dependent upon reliable 
performance at each VI schedule, which was defined as less than 10% variation in the mean IRT 
across 3 consecutive sessions.   
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Manipulation of FMI schedule requirement 
Rats were initially tested on an FMI 0.5-s schedule (with a conjunctive VI 90-s schedule) 
for a minimum of 10 sessions until stability was reached. Performance was deemed stable if the 
average group mean IRT did not vary more than 10% across 3 consecutive sessions and did not 
show any upward or downward trends. Once stability was achieved, subjects experienced one of 
the two experimental conditions (see Experimental conditions section) for one session, then 
returned to baseline conditions for a minimum of three sessions (or until stability was again met), 
and then experienced the second experimental condition. Having completed both experimental 
conditions under the FMI 0.5-s schedule, the target interval was changed to 6 s, 21 s, 6 s and 
finally 3 s again. The stability criterion and arrangement of experimental sessions used with the 
FMI 0.5-s schedule were repeated with each of the other FMI schedules. When the target interval 
for the current FMI schedule was greater than the previous one (as with the first 6-s schedule and 
the 21-s schedule), rats were trained up to the new target interval by increasing the criterial time t 
by 1.25% after each correct IRT, until the criterial time reached the target interval (either 6 or 21 
s; this procedure required increasing the criterion from 0 s to 0.01 s). When the target interval for 
the current FMI schedule was shorter than the previous one (second 6-s schedule and 3-s 
schedule), the shorter FMI was imposed immediately. Sessions lasted for 1 h or until 150 
reinforcers were obtained, whichever occurred first, except during the FMI 21-s testing when the 
session length was increased to 2 h to allow for more trials to be completed within each session. 
Experimental Conditions 
Two experimental conditions were implemented, Pre-feeding and Mediated, but only 
data from the Pre-feeding condition is reported here; data from the Mediated condition are not 
reported because no meaningful effect of this condition was observed on FMI performance. In 
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the Pre-feeding condition, rats were provided an additional 1 hr ad libitum access to food in their 
homecage immediately prior to testing. In the Mediated condition (not reported), one Nylon bone 
from the homecage of each rat was placed in the operant chamber during testing. At the end of 
the session the nylon bone was returned to the homecage it came from. In each FMI schedule the 
order of experimental conditions were presented was randomly determined, except for the 
second FMI 6-s instantiation where experimental conditions were presented in the order opposite 
of how they were presented in the first instantiation.  
  Data Analysis 
Latencies were defined as the intervals between trial onset and initial response (Figure 1); 
post-R latencies were those of trials that followed a reinforced trial; post-N were those of trials 
that followed non-reinforced trials, and the first trial in each session. IRTs were defined as the 
intervals separating initial and terminal responses. On each FMI schedule, data analysis was 
conducted on the latencies and IRTs the last 3-4 sessions prior to each experimental condition 
(Baseline sessions), and from Pre-feeding sessions. Two types of analysis were conducted: The 
first analysis was based on the comparison of descriptive statistics (median latencies, mean 
IRTs); the second analysis was focused on the distribution of IRTs, based on estimates from the 
Temporal Regulation model of response-withholding performance (Sanabria & Killeen, 2008a). 
Temporal Regulation model  
According to the Temporal Regulation model, only a proportion of IRTs are sensitive to 
the timing of reinforcement, and are thus labeled timed IRTs; the remainder are non-timed IRTs. 
Non-timed IRTs are terminated at random times with constant probability, and are therefore 
exponentially distributed. Timed IRTs, on the other hand, are terminated when the subjective 
time exceeds a response threshold, yielding a gamma distribution of timed IRTs (see Sanabria & 
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Killeen, 2008, for details on the generation of timed IRTs). Therefore, IRTs are distributed 
according to this function:  
p(IRT = t | t ≤ δ) = 0
p(IRT = t | t > δ) = PΓ t −δ;N,c( )+ 1−P( ) 1k
$
%
&
'
(
)e
−
t−δ
k
           N, c, k, δ ≥ 0; 0 ≥ P ≥1  (1)         
Our primary index of response inhibition was θ = (Nc + δ)/ t, the mean of the gamma-
distributed, timed waiting intervals.  Parameter P is the proportion of timed waiting intervals.  
Increases in P reflect an increase in gamma distributed waiting intervals relative to exponentially 
distributed waiting intervals. In FMI 0.5-s, performance is expected to depend primarily on the 
motoric demands of the task, which may result in distributions of IRTs that are not predictable 
from performance at longer withholding criteria. Therefore TR model parameters θ and P were 
not estimated from the FMI 0.5-s performance.  
Inferential statistics 
Dependent measures were compared across the two FMI 6 s instantiations to ensure that 
they did not vary significantly across instantiations. Median post-R and post-N latencies obtained 
from FMI 6 s conditions were compared using a 2 x 2 (Instantiation x Trial type) repeated 
measures ANOVA. Mean IRTs and mean estimates of TR model parameters θ and P were 
compared across instantiations using paired samples t-tests. Having established that dependent 
variables did not differ significantly across FMI 6 s conditions within each experiment they were 
consolidated into one average FMI 6 s condition.  
Descriptive statistics were compared to determine whether pre-feeding and withholding 
interval had a significant effect on median latencies and mean IRTs, implementing a 2 (Baseline 
vs. Pre-feeding) x 4 (FMI 0.5-s vs. 3-s vs. 6-s vs. 21-s) within-subject ANOVA. When sphericity 
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could not be assumed according to Mauchly’s test, a Huynh-Feldt correction was implemented. 
Significant interaction effects were followed up with 2-tail t-tests.  
  TR model parameters θ and P were estimated for individual subjects from the pooled 
distribution of IRTs across the last 3 Baseline sessions and the Pre-feeding session. Two 2 
(Baseline vs. Pre-feeding) x 3 (FMI 3-s vs. 6-s vs. 21-s) repeated measures ANOVAs were used 
to compare estimates of θ and P across conditions. The statistical significance threshold was set 
at p = .05 for all analyses.   
Results 
One rat developed seizures during testing and therefore its data were excluded from all 
analyses.  
Latencies  
 A 2 (Instantiation) x 2 (Latency type: post-R vs. post-N) ANOVA comparing latencies 
across the two instantiations of the FMI 6 s schedule yielded no significant main effect of 
instantiation (F (1,8) = 0.175, p = 0.4686) and no instantiation x latency type interaction (F (1,8) 
= 0.013, p = 0.912). Therefore post-R and post-N latencies were both averaged for each 
condition across the two FMI 6 s instantiations. 
Figure 1 depicts post-R and post-N latencies. A 4 (Schedule) x 2 (Condition) ANOVA 
conducted on post-R latencies revealed a significant main effect of schedule (F (1.348, 10.784) = 
14.615, p = 0.002).  Pairwise comparisons indicated that post-R latencies in the FMI 21-s 
schedule were longer than the FMI-0.5-s (p = .002), 3-s (p = .002) and 6-s (p = .016) schedules. 
FMI 6-s post-R latencies were also significantly longer than FMI 3-s latencies (p = .048).  
A 4 (Schedule) x 2 (Condition) ANOVA was also conducted on post-N latencies and 
revealed a significant Schedule x Condition interaction (F (1.667, 11.671) = 10.628, p = 0.003). 
19	  
Paired samples t-tests compared Baseline and Prefeeding post-N latencies at each FMI schedule. 
Prefeeding significantly increased post-N latencies relative to baseline in the FMI 3 s (t (8)= 
2.545, p = 0.034), FMI 6 s (t (8) = 3.165,p = 0.013) and FMI 21 s (t (7) = 4.185, p = 0.004) 
schedules. 
 
 
 Figure1. Mean ± SEM median post-R (left column) and post-N (right column) latencies 
across conditions and FMI schedules. Asterisks indicate a significant difference from Baseline (p 
< .05).  
 
IRTs  
 
Paired samples t-test comparing mean IRTs across the two instantiations of the FMI 6 s 
schedule was non-significant (t (8) = 0.146, p = 0.888).  Therefore, IRTs were averaged for each 
condition across the two FMI 6 s instantiations. 
Figure 2 depicts mean IRTs. Feeding condition and FMI schedule had significant main 
(Feeding condition F (1,8) = 6.821, p = 0.031; FMI schedule: F (1.890, 15.116 = 198.633, p < 
0.001) and interaction effects (F (2.923, 23.386) = 6.435, p =0.003) on mean IRTs. IRTs 
increased as a function of pre-feeding (p = 0.031) and across FMI schedules (all pairwise 
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comparisons p values ≤ 0.011).  Pre-feeding significantly increased IRTs above baseline levels in 
the FMI 3 s (t (8) = 2.795, p = 0.023) and FMI 21 s (t (8) = 2.574, p = 0.033) conditions. 
 
Figure 2. Mean (± SEM) IRTs plotted across Baseline (filled triangles) and Prefeeding (open 
circles) conditions at each FMI schedule. Error bars represent SEM. Asterisks indicate a 
significant difference from baseline (p < 0.05).  
 
Response inhibition capacity (θ) 
A 2 x 3 (feeding condition x schedule) repeated measures ANOVA comparing estimates 
of θ revealed a significant schedule x feeding condition interaction effect (F (2, 16) = 6.937, p = 
.007). Post-hoc paired samples t-tests showed that pre-feeding significantly increased estimates 
of θ at the FMI 3-s schedule (t(8) = 2.633, p = .030).  Post-hoc analyses comparing θ values 
across schedules at each condition revealed a significant main effect of schedule for Baseline (F 
(2,16) = 11.413, p = .010) with pairwise comparisons showing that estimates at θ were 
significantly lower at the FMI 21 s schedule compared to the 3-s (p = .004) and 6-s (p < .001) 
schedules.  During the pre-feeding condition a significant main effect of schedule was also 
detected (F (2,16) = 12.42, p = .003) with pairwise comparisons showing that pre-feeding 
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estimates of θ were significantly greater at the FMI 3-s schedule than the 6-s (p = .012) and 21-s 
(p = .004) schedules.  
 
Figure 3. Estimates of θ  plotted across Baseline (filled triangles) and Pre-feeding (open circles) 
conditions at each FMI schedule. Error bars represent SEM. Asterisks indicate a significant 
difference from baseline (p < 0.05).  
 
Proportion of timed responses (P) 
 
Figure 4 depicts estimates of P across FMI schedules and Baseline and Pre-feeding 
conditions. A 2 x 3 repeated measures ANOVA detected a significant interaction effect (F (2,16) 
= 9.488, p = .002). Post-hoc paired samples t-tests showed that pre-feeding significantly 
increased estimates of P at the FMI 6-s schedule (t (8) = 3.118), p = .014), and decreased 
estimates of P at the FMI 21-s schedule (t(8) = 3.243, p = .012). Post-hoc ANOVA revealed that 
P increased significantly as a function of schedule during Baseline condition (F (2,16) = 5.692, p 
= .044) with pairwise comparisons indicating that estimates of P were significantly lower at the 
FMI 21-s schedule than the 3-s (p = .040) and 6-s (p = .017) schedules.  
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Figure 4. Estimates of P plotted across Baseline (filled triangles) and Pre-feeding (open circles) 
conditions at each FMI schedule. Error bars represent SEM. Asterisks indicate a significant 
difference from baseline (p < 0.05).  
 
Discussion 
 Pre-feeding has been used as an effective method to reduce motivation across a variety of 
behavioral tasks (Bizarro & Stolerman, 2003; Galtress, Marshall, & Kirkpatrick, 2012; 
Kolokotroni, Rodgers, & Harrison, 2011; Mazur et al., 2014). Additionally, in the 5-CSRTT pre-
feeding has also been shown to affect estimates of RIC (Bizarro & Stolerman, 2003), whereas in 
the FMI estimates of RIC are spared from pre-feeding effects (Mazur et al., 2014). We showed 
that pre-feeding effects on measures of motivation and RIC depend on the FMI schedule in 
effect. At the FMI 0.5-s schedule, pre-feeding had no effect on any dependent measure. It was 
assumed that performance on the FMI 0.5-s schedule reflects the motoric demands of the task 
because waiting requirements are negligible. Pre-feeding did not affect performance on the FMI 
0.5-s schedule, which suggests that this manipulation did not affect the basic motor requirements 
of the task.  These results are inconsistent with previous assertions that pre-feeding primarily 
affects speed of responding (Kolokotroni et al., 2011). Had pre-feeding affected response speed 
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independently of other processes controlling performance, it would be expected that FMI 0.5-s 
schedule performance would be affected.  
 Pre-feeding induced increases in post-N latencies at the FMI 3, 6, and 21-s schedules was 
in the predicted direction and supports the use of latencies as an index for motivation. Notably, 
post-R latencies were unaffected by pre-feeding. Chronic stress also lengthens post-N but not 
post-R latencies (Mika et al., 2012). Collectively, these results suggest that although chronic 
stress and pre-feeding decrease motivation, but that reinforcement temporarily restores 
motivation to baseline levels.  
 Our prediction that RIC would be robust against the effects of pre-feeding was only 
partially supported. Pre-feeding increased mean IRTs at the FMI 3 and 21-s schedules but not the 
FMI 0.5 and 6-s schedules. Furthermore, only estimates of θ derived from the FMI 3-s schedule 
were sensitive to pre-feeding effects. It is unclear why pre-feeding selectively increased 
estimates of θ on the FMI 3-s schedule and not the 6-s or 21-s schedules. However, these results 
suggest that estimates of θ derived from the FMI are not universally sensitive to pre-feeding 
effects. It is possible that pre-feeding effects on θ are only evident when the FMI requirement is 
low.  
 The discrepancy in pre-feeding effects on IRTs and θ at the FMI 21-s schedule suggest 
that pre-feeding primarily affected the proportion of non-timed (i.e., exponentially distributed) 
IRTs, and not the proportion of timed (i.e., gamma distributed) IRTs from which θ was 
estimated. Estimates of P increased with pre-feeding at the FMI 21-s schedule, indicating that a 
larger proportion of the IRT distribution was made up of non-timed IRTs during the pre-feeding 
condition than during Baseline.  
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Experiment 2 
Method 
Subjects and Apparatus 
 The 9 subjects from Experiment 1 were included in this experiment, immediately after 
Experiment 1 was completed on PND 244. Housing and feeding conditions were identical to 
those described in Experiment 1. The same test chambers and reinforcers were used in this 
experiment. 
Procedure 
Baseline condition 1  
Rats were trained on the FMI 6-s schedule, under conditions and stability criteria 
identical to those described as Baseline in Experiment 1, including the conjunctive VI 90-s 
schedule. After reaching stability, half of the rats were assigned to the VI 0 s condition and the 
other half to the Larger Reinforcer condition. Assignment was determined by performance 
during the last three Baseline sessions such that mean IRT and median latencies did not vary 
more than 0.5 s between groups. 
VI 0 s condition  
Reinforcement contingencies were similar to those in Baseline, except that the 
conjunctive VI schedule was reduced from 90 to 0 s. In this schedule, every correct response was 
reinforced. The VI 0 s condition lasted for 11-13 sessions, and was followed by a reinstatement 
of Baseline conditions (see Baseline condition 2). 
Larger Reinforcer condition  
Reinforcement was arranged on a VI 90-s schedule just as during Baseline, but the 
reinforcer was increased from 1 to 4 sucrose pellets. The maximum number of trials per session 
25	  
was reduced from 150 to 37, so that the total number of reinforcers available per session was 
approximately equivalent to Baseline. The Large Reinforcer condition lasted for 11-13 sessions, 
and was followed by a reinstatement of Baseline conditions (see Baseline condition 2).  
Baseline condition 2 
Once stable performance was obtained under the VI 0 s or Large Reinforcer conditions, 
whichever was experienced first, Baseline conditions (i.e., FMI 6-s with conjunctive VI 90-s 
reinforced with 1 pellet) were reinstated. Rats completed a minimum of 10 sessions and 
continued testing until stability criteria were met. Following stable performance, either VI 0 s or 
Large Reinforcer conditions were implemented, whichever had not been experienced. 
Data Analysis 
Median latencies and mean IRTs were compared across the two Baseline conditions to 
ensure that they did not vary significantly across instantiations. Median post-R and post-N 
latencies obtained from Baseline conditions were compared using a 2 x 2 (Instantiation x Trial 
type) repeated measures ANOVA. Mean IRTs were compared across Baseline conditions using 
paired samples t-tests. Having established that dependent variables did not differ significantly 
across Baseline conditions within each experiment they were consolidated.  
Latencies and IRTs were collected from the last 5 sessions in each condition and used for 
analysis. TR model parameters θ and P were estimated for individual subjects from the pooled 
distribution of IRTs across the last 3 sessions of each condition. The analysis of descriptive 
statistics involved the comparison of median latencies, mean IRTs and estimates of θ and P  
obtained under Baseline conditions (Baseline 1 and 2 data were pooled within subjects) against 
those obtained under VI 0 s and Large Reinforcer conditions using t-tests and a significance 
criterion of α = .05.  
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Results 
Latencies 
Paired samples t-tests compared mean post-R and post-N latencies across both FMI 6 s 
baseline instantiations. Results revealed that neither post-R (t (8) = 0.382, p = 0.712) or post-N (t 
(8) = 0.564, p = 0.588) latencies varied significantly across instantiations so therefore they were 
averaged across instantiations for each latency type.  
Increasing the magnitude of reinforcement from 1 (Baseline) to 4 (Large Reinforcer) 
sucrose pellets increased post-R latencies (t (8) = 4.757, p = 0.001) but decreased post-N 
latencies (t (8) = 3.766, p = 0.005) (see Figure 5).  
 
Figure 5. Mean median post-R (left panel) and post-N (right panel) latencies plotted across 
Baseline  and Large Reinforcer (top panels) conditions. Error bars represent SEM. Asterisks 
indicate a significant difference from baseline (p < 0.05).  
 
Post-R latencies decreased significantly when the conjunctive VI-90 s schedule 
controlling reinforcement rates was eliminated (VI 0 s condition) (t (8) =3.610, p = 0.007) (see 
Figure 6). 
27	  
 
Figure 6. Mean median post-R (left panel) and post-N (right panel) latencies  plotted across 
Baseline  and VI 0-s conditions. Error bars represent SEM. Asterisks indicate a significant 
difference from baseline (p < 0.05).  
 
IRTs 
Paired samples t-tests compared mean IRTs across both FMI 6 s baseline instantiations 
and revealed that did not significantly vary (t (8) = 0.229, p = 0.825) so they were averaged 
across instantiations. 
Mean IRTs were not significantly affected when the conjunctive VI-90 s schedule was 
eliminated (t (8) = 2.174, p = 0.061) or when the magnitude of reinforcement was increased to 4 
pellets (t (8) = 1.003, p = 0.345) (see Figure 7). 
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Figure 7. Mean IRTs  plotted across Baseline, Large Reinforcer and VI 0-s conditions. Error bars 
represent SEM. Asterisks indicate a significant difference from baseline (p < 0.05).  
 
Temporal Regulation model parameters 
Estimates of θ were not significantly affected by increasing the magnitude of 
reinforcement (t (8) = 1.209, p = .227) or decreasing the conjunctive VI schedule (t(8) = 1.429, p 
= .191) (see Figure 8). Estimates of P were not significantly affected by changes to the reinforcer 
magnitude (t(8) = 2.045, p = .075) or reinforcer frequency (t (8) = 1.969, p = .084) (see Figure 
9). 
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Figure 8. Estimates of θ  comparing Baseline and the Large Reinforcer condition (upper panel) 
and with the VI 0 s condition (lower panel). Error bars represent SEM.  
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Figure 9. Estimates of P comparing Baseline and the Large Reinforcer condition (upper panel) 
and with the VI-0 s condition (lower panel). Error bars represent SEM.  
 
Discussion 
 Experiment 2 expands the validation test of the FMI schedule to two new experimental 
manipulations, rate of reinforcement and reinforcer magnitude. Previous research has shown that 
increasing the magnitude of reinforcement decreases estimates of RIC derived from the DRL 
task (Doughty & Richards, 2002; Kirshenbaum et al., 2008). Results from Experiment 2 
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demonstrated that FMI latencies are substantially more sensitive to changes in magnitude and 
frequency of reinforcement than IRTs or θ. Specifically, increasing the magnitude of 
reinforcement increased post-R and decreased post-N latencies. Increasing the rate of 
reinforcement decreased post-R but had no significant effect on post-N latencies. Decreases in 
latencies are consistent with the prediction that manipulations of rate and magnitude of 
reinforcement enhanced reinforcer efficacy, leading to an increase in motivation. Increases in 
post-R latencies in the Large Reinforcer condition suggest that this manipulation reduced 
reinforcer efficacy and motivation; however, alternative explanations may account for this effect. 
For example, postprandial behavior may have contributed a greater amount to latencies when the 
amount of reinforcement increased (Rickard, Body, Zhang, Bradshaw, & Szabadi, 2009). It is 
also possible that increasing the reinforcer magnitude enhanced that discriminative function of 
reinforcement signaling a period of non-reinforcement (Ferster & Skinner, 1957; Priddle-Higson, 
Lowe, & Harzem, 1976; Skinner, 1938). In the present experiments, the conjunctive VI schedule 
delivered reinforcement on the trial following the completion of the VI, which implied that 
reinforcement could not be delivered on consecutive trials. Thus, subjects may have learned that 
reinforcement signaled an upcoming non-reinforced trial and increasing the magnitude of 
reinforcement enhanced this association.  
 Conclusion 
 The purpose of this study was to validate the FMI schedule of reinforcement as a 
behavioral paradigm to assess the ability of rodents to withhold an instrumentally reinforced 
response (response inhibition capacity, or RIC). In particular, this study was aimed at 
determining whether the index of RIC derived from the FMI, θ, was robust against changes in 
level of deprivation, rate of reinforcement, and magnitude of reinforcement. Results from 
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Experiment 1 demonstrated that estimates of θ were less sensitive to pre-feeding effects than 
latencies. Only one of the FMI schedules examined (FMI 3 s) was sensitive to pre-feeding 
effects, suggesting that estimates of θ derived from the FMI are not universally affected by pre-
feeding manipulations. Results from Experiment 2 showed that estimates of θ are robust against 
changes to rate and magnitude of reinforcement. Collectively, results from Experiments 1 and 2 
demonstrate the differential sensitivity of latencies, but not θ, to changes in reinforcer efficacy. 
This differential sensitivity implies that, unlike other methods of assessing RIC in rodents (Beer 
& Trumble, 1965; Bizarro & Stolerman, 2003; Conrad et al., 1958; Doughty & Richards, 2002; 
Holz & Azrin, 1963; Kirshenbaum et al., 2008; Tanno et al., 2011), the FMI schedule effectively 
dissociates incentive-motivational effects from inhibitory effects. In conclusion, these results 
support the use of the FMI schedule and its associated analytic techniques as tools for assessing 
RIC in animal models.   
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CHAPTER	  3	  INVESTIGATING	  THE	  ROLE	  OF	  COLLATERAL	  BEHAVIOR	  ON	  FIXED	  MINIMUM	  INTERVAL	  (FMI)	  SCHEDULE	  PERFORMANCE	  IN	  THE	  SPONTANEOUSLY	  HYPERTENSIVE	  RAT	  (SHR)	  
Impulsivity is a multifaceted construct referring to a spectrum of behaviors that can be 
described as “poorly conceived, prematurely expressed, unduly risky, or inappropriate to the 
situation and that often result in undesirable outcomes” (Daruna & Barnes, 1993). It refers to not 
just one type of behavior, but rather multiple behaviors, each with potentially unique biological 
underpinnings (Evenden, 1999; Winstanley et al., 2006). The ability to withhold a reinforced 
response, or response inhibition capacity (RIC), is one aspect of impulsivity that is thought to be 
a core deficit of attention-deficit hyperactivity disorder (ADHD) (Barkley, 1997; Bellgrove et al., 
2005; Chambers et al., 2009). Impaired RIC has also been linked to other psychopathologies 
including substance abuse (de Wit, 2009; Perry & Carroll, 2008) and borderline personality 
disorder (BPD)(Chapman, Leung, & Lynch, 2008; Nigg, Silk, Stavro, & Miller, 2005).   
The differential reinforcement of low rates (DRL) schedule is one of several methods of 
assessing RIC in both humans (Dickerson et al., 2001; Gordon, 1979) and non-human animals 
(Doughty & Richards, 2002; Hill et al., 2012; Kirshenbaum et al., 2008; Orduña et al., 2009; 
Popke et al., 2000; Sanabria & Killeen, 2008). In the DRL schedule, an operant response is 
reinforced if it is separated from the preceding response by an interval of a fixed minimum 
duration. Responses made prematurely are not reinforced, but rather reset the clock that 
programs reinforcement. The DRL schedule generates behavior that is sensitive to the passage of 
time (Conrad et al., 1958;  Evenden, 1999; Staddon, 1965); the parameters of the distribution of 
intervals separating consecutive responses (inter-response times, or IRTs) provide the main 
dependent measure of DRL performance (Lewis & Dougherty, 1992). With sufficient training, 
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subjects learn to withhold premature responding in such a way that a frequency distribution of 
IRTs peaks near the programmed criterion interval.  
DRL schedule performance is frequently used when diagnosing ADHD (Dickerson et al., 
2001). Individuals with ADHD have been shown to perform worse on the DRL schedule (i.e., 
produce more premature responses) than controls (Dickerson et al., 2001; Gordon, 1979). 
Performance is often described as “inefficient” in that the “efficiency ratio” of non-reinforced to 
reinforced responses is low (Dickerson et al., 2001). These findings support the use of the DRL 
schedule in differentiating between impulsive and non-impulsive individuals. Further support 
comes from animal studies showing that Spontaneously Hypertensive rats (SHR), the most 
validated animal model of ADHD (Russell, 2011; Sagvolden, 2000) perform less efficiently on 
the DRL schedule than their normotensive parent strain, the Wistar Kyoto (WKY) rat (Orduña et 
al., 2009; Sanabria & Killeen, 2008; van den Bergh et al., 2006). Collectively these studies 
support the use of the DRL as a method for assessing ADHD-like deficits in RIC in human and 
non-human animals (see Bull et al., 2000 for an exception).  
However, inferences on impulsivity based upon DRL schedule performance, and 
specifically those drawn from efficiency ratios, are compromised by findings demonstrating that 
impulsivity is one of many factors that can account for impaired, or inefficient, DRL schedule 
performance. For instance, DRL performance is sensitive to experimental manipulations that 
influence the effectiveness of the reinforcer, such as level of deprivation (Conrad et al., 1958; 
Holz & Azrin, 1963; Tanno et al., 2011) and reinforcer magnitude (Beer & Trumble, 1965; 
Doughty & Richards, 2002; Kirshenbaum et al., 2008). Using food as a reinforcer, the 
distribution of DRL IRTs is shifted leftwards in rats maintained at a lower weight relative to 
those maintained at a higher weight (Tanno et al., 2011). A similar effect is observed in rats and 
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pigeons when larger reinforcers are used (Doughty & Richards, 2002; Kirshenbaum et al., 2008). 
These results suggest that more efficacious reinforcers disrupt DRL performance.  
DRL performance is also sensitive to the availability of support for collateral behaviors 
(non-reinforced behaviors that occur between consecutive operant responses; Gordon, 1979; 
Laties et al., 1969, 1965; Stein and Landis, 1973). In rodents, engaging in collateral behaviors 
improves DRL performance (Laties et al., 1965, 1969), whereas performance deteriorates when 
rats are restrained and unable to engage in collateral behavior (Glazer & Singh, 1971; Laties et 
al., 1969). Similar effects have been observed in humans (Stein & Landis, 1973). Children with 
ADHD have been shown to engage in higher rates of collateral behaviors during DRL testing 
than controls, but these collateral responses are inversely correlated with performance (Gordon, 
1979).  
In the present study we examined the role of collateral behavior on RIC using a variation 
of the DRL, the Fixed Minimum Interval (FMI; Mechner and Guevrekian, 1962).  The goal of 
this study was to determine whether RIC is affected by collateral behavior in the SHR model of 
ADHD. To attain this goal, rats trained on FMI had access to an extended lever during the IRT, 
which permitted collateral responding. Once FMI performance was stable for all subjects, the 
lever was removed during the IRT and performance in this “No Lever” condition was compared 
to Baseline.  
Method 
Subjects 
Sixteen male spontaneously hypertensive rats (SHR; n = 8) (Charles River, Hollister, 
California) and Wistar Kyoto rats (WKY; n = 8) (Harlan, Indianapolis, Indiana) served as 
subjects. All rats arrived on postnatal day (PND) 45 and were immediately pair-housed in a 
36	  
colony room with a 12:12-h day:night cycle, with lights on at 1900 h. Upon arrival food was 
available ad libitum in the homecage, but was gradually reduced to 1 h daily access provided 30 
min after the end of each experimental session. Water was available ad libitum throughout 
experimentation. All experimental protocols were conducted in accordance with the guidelines 
provided by the National Institutes of Health and approved by the Arizona State University 
Institutional Animal Care and Use Committee.  
Apparatus 
Experiments were conducted in 16 MED Associates (St. Albans, VT) modular test 
chambers (three were 305 mm long, 241 mm wide, and 210 mm high; thirteen were 305 mm 
long, 241 mm wide, and 292 mm high), each of which was enclosed in a sound- and light-
attenuating box equipped with a ventilation fan. The front/back walls and the ceiling of the test 
chambers were made of Plexiglas; the front wall was hinged and served as a door to the chamber. 
One of the two aluminum side panels served as a test panel. The floor consisted of 5-mm steel 
rods spaced 16 mm apart and positioned 36 mm above a catch pan. A square opening (51 mm 
each side) located 15 mm above the floor and centered on the test panel provided access to a 
dipper (MED Associates, ENV-202M-S) fitted with a cup (MED Associates, ENV-202C) 
containing 0.01 cc of sweetened condensed milk solution (33% sweetened condensed milk 
diluted in tap water; Great Value brand, Walmart, Bentonville, AK) which was delivered to the 
hopper with each activation of the dispenser. A multiple tone generator (MED Associates, ENV-
223) was used to produce 3 kHz tones at approximately 75 dB through a speaker (MED 
Associates, ENV-224AM) centered on the top of the wall opposite to the test panel, 240 mm 
above the floor of the chamber. Two retractable levers (ENV-112CM) were located on either 
side of the food hopper. Three-color light stimuli (ENV-222M) were mounted 35 mm above 
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each lever; they could be illuminated yellow, green, and red. A force of approximately 0.2 N 
applied to the end of the lever was necessary for a lever press to be recorded. The ventilation fan 
mounted on the rear wall of the sound-attenuating chamber provided masked noise of 
approximately 60 dB. Experimental events were arranged via a Med-PC® interface connected to 
a PC controlled by Med-PC IV® software. 
 Procedure 
 Sessions were conducted daily, 7 days per week. Training started with one session of 
chamber habituation followed by four sessions of hopper training during which reinforcement 
was presented on a variable time (VT) 15-s schedule. Once all rats were reliably consuming all 
reinforcers, autoshaping began during which lever insertion was paired with the delivery of 
reinforcement. Once all rats were reliably responding for reinforcement FMI training began. At 
the onset of training the FMI criterion was set to 0.5 s and increased by 1.25% after every correct 
response until rats reached the 4.5 s where it remained constant for the remainder of testing. 
Once the 4.5 s criterion was reached the probability of the availability of reinforcement changed 
from 100 percent to 30 percent. At the beginning of each trial there was a 30 percent chance that 
reinforcement would be available for a correct response. Once reinforcement was set up, its 
availability was carried over from trial to trial until a correct response was recorded. During each 
session trials started with the extension of the lever which occurred 2 s following the removal of 
the rats head from the hopper. The inter-trial interval (ITI), was recorded for each animal. After 
the lever was extended, the first response initiated the IRT. The lever remained extended for the 
remainder of the trial until a terminal head-entry was made. During the IRT the number of lever 
presses made were recorded but produced no consequence. Once Baseline performance 
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stabilized the lever was removed during the IRT for 2 sessions (No Lever condition). Sessions 
lasted 1 h or after 100 reinforcers were earned, whichever occurred first.  
Data Analysis 
 Median Post-R and Post-N latencies, mean IRTs and mean inter-trial intervals (ITIs) 
were calculated daily for individual rats. The proportion of correct IRTs (IRTs ≥ 4.5 s) and the 
total number of additional lever presses emitted were also calculated daily for individual 
subjects. Each of these dependent measures was averaged across the final three sessions for 
individual rats. Latencies, IRTs and ITIs were log transformed. The proportion of correct IRTs 
were log-odds transformed. These transformations are based on suggestions by Chueng et al. 
(2012). All dependent measures are reported as back transformed values.  
Temporal Regulation (TR) model  
The TR model (Equation 1) was used to describe IRT distributions. TR model parameter 
θ was calculated for each subject from the pooled distribution of IRTs from the last three 
sessions.  
 
p(IRT = t | t ≤ δ) = 0
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Inferential statistics 
 Median Baseline post-R and post-N latencies and mean ITIs were analyzed separately 
using independent t-tests. Mean Baseline and “No Lever” IRTs were compared using a 2 x 2 
(Strain x Condition) ANOVA. Our analysis was primarily concerned with mean timed IRTs, or θ 
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= (Nc + δ)/4.5. θ was estimated for each subject from the pooled distribution of IRTs from the 
last 3 sessions. Baseline and No Lever estimates of TR model parameter θ was compared using a 
2 x 2 (Strain x Condition) ANOVA. Independent t-tests were used to compare the proportion of 
correct IRTs and the average number of additional lever presses (i.e., collateral behavior) from 
the last 3 Baseline sessions. All dependent measures were log-transformed for analysis, except 
the proportion of correct IRTs, which were log-odds transformed; all measures are reported 
back-transformed. The statistical significance threshold was set at p = .05.  
Results 
Latencies 
Figure 10 depicts strain differences in mean median Post-R and Post-N latencies. 
Independent samples t-tests revealed that during the last 3 baseline sessions, SHRs had 
significantly shorter Post-R (t (14) = 4.31, p = .001) and Post-N (t(14) = 2.98, p = .010) latencies 
relative to WKYs 
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Figure 10. Mean (± SEM) median Post-R (top panel) and Post-N (bottom panel) latencies for 
SHRs and WKYs. Asterisks indicate a significant strain difference (p < .05). 
 
 
Inter-trial Intervals (ITIs) 
Mean ITIs are shown in Figure 11.Independent samples t-tests revealed that mean ITIs 
were significantly shorter for WKYs than SHRs (t(14) = 2.36, p = .034). 
41	  
 
Figure 11. Mean (± SEM) inter-trial intervals (ITIs) plotted for SHR and WKY rats. 
Asterisks indicate a significant strain difference (p < .05). 
 
Mean IRTs 
The effects of strain and condition on mean IRTs are shown in Figure 12. A 2 x 2 (Strain 
x Condition) ANOVA failed to yield a significant effect of condition (F (1,14) = .58, p = .459) or 
strain (F (1,14) = 2.71, p = .122) on mean IRTs (Figure 11). A 2 x 2 (Strain x Condition) 
ANOVA failed to yield a significant effect of condition (F (1,14) = .65, p = .432) or strain (F 
(1,14) = 2.90, p = .110) on estimates of θ. 
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Figure 12. Mean (± SEM) IRTs plotted for SHR (filled triangles) and WKY (open 
circles) rats.  
 
Additional Lever Presses and Correct IRTs Correlation 
 
Independent samples t-tests failed to yield a significant strain difference for the number 
of additional lever presses emitted during the IRT (t(14) = 0.94, p = .365) or the proportion of 
correct IRTs (t(14) = 1.39, p = .186).  Pearson product-moment correlations calculated for the 
proportion of correct IRTs and the number of additional lever presses was not significant for 
either SHRs or WKYs (p values > .05) (see Figure 13).  
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Figure 13. Scatter plot proportion of correct IRTs (≥ 4.5 s) and number of additional lever   
presses for SHRs (filled triangles) and WKYs (open circles).  
 
Discussion 
Engaging in collateral behavior improves DRL schedule performance in both humans 
(Stein & Landis, 1973) and rodents (Laties et al., 1965, 1969). Children with ADHD engage in a 
greater percentage of overt collateral responses on the DRL task than their non-diagnosed peers, 
but that collateral behavior is negatively correlated with performance (Gordon, 1979). Like 
children with ADHD, the SHR performs worse than controls on the DRL (Sanabria & Killeen, 
2008b). It is unclear whether SHRs engage in greater amount of collateral behavior than controls 
or whether collateral behavior is related to impaired DRL performance. The goal of the present 
study was to examine the relationship between collateral behavior and performance in SHRs 
using a response-withholding task similar to the DRL, the FMI.  
The results from this study suggest that, unlike children with ADHD (Gordon, 1979), 
SHRs do not engage in more collateral behavior than controls, and that collateral behavior is not 
related to FMI performance in either strain. These results do not preclude the possibility that 
SHRs did engage in greater amounts of collateral behaviors other than lever pressing. Gordon 
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(1979) reported that only a quarter of the children with ADHD engaged in the programmed 
collateral response (i.e., key presses); the majority of the children engaged in some other form of 
overt response that was unique to each child. Thus, it is possible that SHRs engage in other 
forms of collateral responses that we were unable to measure. If rats engage in some other form 
of collateral behavior besides the lever presses we measured, this could potentially explain the 
absence of a correlation between FMI performance and collateral lever presses.   
Strain differences emerged in the form of latencies and mean ITIs; SHRs had shorter 
post-R and post-N latencies and longer mean ITIs. These results are inconsistent with previous 
findings from our lab showing that latencies on an FMI 6-s schedule do not differ between SHR 
and WKYs (Mazur et al., 2014). These inconsistencies may be related to slight modifications we 
made to the FMI task in the present study. Specifically, in the present study ITIs were 
programmed to last a minimum of 5 s and to continue until 2 s after the rat removed it’s head 
from the hopper. In the Mazur et al. (2014) study ITIs were 5.5 s regardless of whether the rats 
head was still in the hopper at the end of the interval. Therefore, in Mazur’s study, any time the 
rat spent with its head in the hopper following the 5.5 s ITI would have been considered part of 
the latency to the next trial. Potentially, the reason Mazur et al. did not observe strain differences 
in latencies, while we showed that SHRs made shorter latencies and longer ITIs in the present 
study, is because we included the time rats spent in the hopper as part of the ITI, whereas Mazur 
would have counted that time as part of the latency to the next trial.  
The strain differences in mean ITIs, which was due to SHRs spending more time in the 
hopper, is consistent with previous reports showing that SHRs spend more time goal-tracking 
than WKYs (Chow, Bardo, & Beckmann, 2014). Chow and colleagues interpreted strain 
differences in goal-tracking as evidence that the SHR is more inattentive than WKYs. It is 
45	  
unlikely, however, that differences in attention contributed to differences in mean ITIs, an 
interval where attention is least likely to be taxed. Recently, Flagel et al. (2007) found that rats 
that engaged in higher levels of goal-tracking also had greater levels of tyrosine hydroxylase, 
dopamine transporters and D2 receptor mRNA. SHRs have also been shown to have elevated 
levels of D1 and D2 receptors and dopamine transporters in the striatum relative to WKYs 
(Russell, 2002). These strain differences in dopamine receptors may have contributed to strain 
differences in mean ITIs in the present study.  
Conclusion 
 The present study showed that (1) SHRs and WKYs did not significantly differ in the 
amount of collateral behavior they produce during a response withholding task, and that (2) 
collateral behavior was not correlated with FMI performance in either strain. It is possible that 
our definition of collateral behavior was too restrictive and that rats engaged in other forms of 
collateral responses that we were unable to measure in the present study. Results from this study 
showed that SHRs had shorter latencies and longer ITIs. These differences are similar to 
previous results showing strain differences in goal-tracking (Chow et al., 2014), and that 
together, are consistent with reported dopaminergic differences across strains (Russell, 2002).  
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Vulnerability to tobacco dependence is heightened during adolescence (U.S. Department 
of Health and Human Services, 2012). Several factors are associated with increased risk of 
adolescent smoking, including low socioeconomic status, peer smoking, parental smoking, risk 
taking, and comorbid psychopathology (U.S. Department of Health and Human Services, 2012).  
Psychopathologies associated with adolescent smoking include anxiety disorders, depressive 
disorders, conduct disorders and attention-deficit hyperactivity disorder (ADHD) (Lasser, 2000).  
ADHD is a childhood neurobehavioral disorder characterized by excessive levels of 
hyperactivity, inattention, and impulsivity (American Psychiatric Association, 2013); it is a risk 
factor for tobacco dependence (McClernon & Kollins, 2008). The prevalence of smoking among 
adolescents and adults with ADHD is nearly double that of their non-diagnosed peers (Breyer et 
al., 2014; Lambert & Hartsough, 1998; Molina & Pelham Jr., 2003). Adolescent smokers with 
ADHD first experiment with tobacco and progress to regular use at a younger age than non-
ADHD adolescent smokers (Chang et al., 2012). Furthermore, adolescent smokers with ADHD  
are more likely to become tobacco dependent and to continue smoking into adulthood than non-
ADHD adolescent smokers (Breyer et al., 2014; Chang et al., 2012; Lambert & Hartsough, 
1998). Once dependent, individuals with ADHD have greater difficulty quitting and exhibit more 
severe withdrawal symptoms than non-ADHD smokers (Humfleet et al., 2005; Pomerleau, 
Downey, Stelson, & Pomerleau, 1995).  
Recent investigations attempting to uncover factors contributing to the comorbidity 
between tobacco dependence and ADHD have shown differences in the subjective experience of 
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smoking and in the motivational factors that contribute to smoking (Mitchell et al., 2014; Van 
Voorhees et al., 2012). Specifically, smokers with ADHD report that smoking is more calming, 
more reinforcing and provides greater cognitive enhancement; they also report greater 
satisfaction and liking of puffs(Van Voorhees et al., 2012). Smokers with ADHD report 
experiencing smoking-related cues more frequently than non-ADHD smokers which may 
indicate that those cues acquire greater significance for ADHD-smokers (Mitchell et al., 2014).  
It is thus hypothesized that ADHD-related smoking is linked to a heightened sensitivity 
to smoking-related reward and smoking-related cues. The present study experimentally tested 
this hypothesis using an animal model of ADHD, the spontaneously hypertensive rat (SHR).  
The SHR is the most validated animal model of ADHD, displaying its core symptoms 
including inattentiveness (Jentsch, 2005), impulsivity (Sanabria & Killeen, 2008a),  and 
hyperactivity (Hill, Herbst, et al., 2012; Hsieh & Yang, 2008). The SHR has been shown to be 
more responsive to nicotine reinforcement in a self-administration paradigm than its progenitor 
control strain, the Wistar Kyoto (WKY) rat, along with 10 other rat strains (Chen et al., 2012). 
The present study aimed at providing converging evidence of heightened sensitivity to the 
rewarding effects of nicotine using the conditioned place preference procedure (CPP), a 
Pavlovian measure of conditioned drug reward (Le Foll & Goldberg, 2005). Nicotine-induced 
locomotion and preference for a nicotine-paired location served as measures to evaluate the 
differential sensitivity of adolescent SHR to nicotine (Bardo & Bevins, 2000; Benwell & 
Balfour, 1992).  
 
 
 
48	  
Method 
Subjects 
Ninety-two experimentally naïve adolescent male spontaneously hypertensive rats 
(SHR/NCrl; n =44) and Wistar Kyoto rats (WKY/NHsd; n = 48) were used. All rats arrived in 
the colony room on postnatal day (PND) 24 and were immediately pair-housed and provided ad 
libitum access to food and water in their home cages. All animals were handled for at least 2 
minutes per day prior to the beginning of experimentation. Animals were housed in a colony 
room maintained on a 12:12 hr light:dark cycle with lights on at 1900 h. All behavioral training 
was conducted in two sessions per day, separated by 3 hr, during the dark phase. Behavioral 
testing was conducted in a single session on a separate day. All procedures were conducted in 
accordance with the guidelines described in the 8th edition of the Guide for the Care and Use of 
Laboratory Animals, and were approved by the Institutional Animal Care and Use Committee at 
Arizona State University. 
Apparatus 
All behavioral testing was conducted in three identical place-conditioning chambers 
(Med Associates, St. Albans, VT) (53.3 x 34.3 x 1.3 cm), which were interfaced to a PC 
computer that recorded animal activity and location in the apparatus. Test chambers were divided 
into two equally sized compartments separated by an automated stainless steel guillotine door. 
Compartments were equipped with stainless steel grid floors and white stimulus lights located on 
the outside walls of both compartments. Exterior walls were made of clear Plexiglas. Black and 
white striped paper was arranged in opposite directions (vertical vs. horizontal stripes) on the 
outside of the plexiglass walls to make the interior of the compartments visually distinctive.  A 
stainless steel pan was located beneath the grid floor of the chamber. Sanichip bedding was 
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placed on one side of the pan and was separated from corncob bedding placed on the opposite 
side. Locomotor activity was monitored by 16 pairs of photobeams (8 per side) spaced evenly 
along adjacent plexiglass walls. The clock recording time spent in each compartment began 
immediately at the start of each session. A rat was considered to have switched sides if the 
second closest and the closest infrared beams relative to the door on one side were broken, in that 
order, followed by the occlusion of the same beams on the alternate side but in the opposite 
order. After a rat was considered to have switched sides the clock began recording the amount of 
time spent on the newly occupied side.  
Drugs 
Nicotine hydrochloride tartrate (Sigma, St. Louis, MO, USA) was dissolved in saline 
(0.9% NaCl) and adjusted to a pH of 7.2. Both nicotine and saline were administered 
subcutaneously (s.c.) in a volume of 1 ml/kg. Nicotine doses (0.0 (saline), 0.1, 0.3, and 0.6 
mg/kg) were expressed as the freebase weight. Doses were chosen based upon previous studies 
showing that they supported CPP in adolescent rats (Le Foll & Goldberg, 2005).  
Procedure 
The CPP procedure consisted of four phases: acclimation, pre-test, conditioning and post-
test. During the acclimation phase (Day 1), rats were placed in the CPP chamber with the 
guillotine door raised and allowed to explore both compartments for 20 min. Rats were initially 
placed randomly on either the left or right side, with half of each treatment group placed on 
either side. Two acclimation sessions were conducted on Day 1. After the first acclimation 
session rats were placed back in their homecage and returned to the colony room until the next 
acclimation session which was conducted 4 hours later. During the second acclimation session 
rats were initially placed on the side opposite of which they were initially placed for the first 
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acclimation session. During the pre-test phase (Day 2), rats received a saline injection (s.c.) 
immediately prior to each of two 10-min sessions. In these sessions, rats were placed on either 
the left or right compartment with the guillotine door raised, allowing the rat to explore both 
compartments. Between pre-test sessions, rats were placed back in their homecages and returned 
to the colony room. The amount of time spent in each compartment pooled across pre-test 
sessions was used to determine drug assignment and potential side bias. Rats that spent less than 
a total of 350 s (out of 1200 s) on either compartment during the pre-test phase were excluded 
from further testing and their pre-test data were excluded from analyses. 
During the conditioning phase (Days 3-6) rats were injected (s.c.) with either saline or 
nicotine (0.0 (saline), 0.1, 0.3 or 0.6 mg/kg; n= 10-12/dose/strain) and confined to one 
compartment for 20 min. A biased design was used; nicotine was paired with the compartment 
that was less preferred during pre-test (Drug Paired Side). Saline was paired with the 
compartment that was initially preferred during pre-test (No Drug Side). The exception to this 
was the group of rats (n= 10/strain) who received saline injections prior to being placed in both 
the preferred and non-preferred compartments. Rats experienced one conditioning trial per day 
with Drug Paired Side and No Drug Side sessions alternating across the four days of the 
conditioning phase in a counterbalanced order.  
 During the post-test phase (Day 7) rats received no injections prior to being placed in the 
CPP chamber. The side of initial placement was counterbalanced across rats: half of the rats in 
each strain were initially placed in the preferred compartment and half were placed in the non-
preferred compartment. During the 20 min post-test session the guillotine door was raised and 
movement within each compartment was recorded.   
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Data Analysis 
 Difference scores (time spent on the non-preferred side during post-test minus time spent 
on the non-preferred side during pre-test) were calculated for each animal and averaged across 
rats in each nicotine dose group (0.0 (saline), 0.1, 0.3 or 0.6 mg/kg) for each strain. Nicotine CPP 
was defined by difference scores that were significantly greater for the groups receiving nicotine 
injections than for the group receiving saline throughout conditioning. Because an independent t-
test conducted on pre-test data revealed a significant strain effect in time spent in the Drug Paired 
compartment (see Results) difference scores were analyzed separately for each strain in order to 
ensure that pre-test differences did not interfere with the ability to detect positive results.  
Dunnett’s multiple comparisons test (Dunnett, 1955) was implemented to compare difference 
scores for the Saline group and each nicotine group across strains.  
Locomotor activity was assessed by calculating the number of beam breaks on the Drug 
Paired and No Drug compartments during conditioning sessions. Because an independent t-test 
revealed that pre-test locomotor activity was significantly higher for SHRs than for WKYs (see 
Results), locomotor activity was analyzed separately for each strain. Locomotor activity was 
compared across strains during conditioning using two 2 (Compartment) x 4 (Dose) ANOVAs. 
For all analyses significance was set at p = 0.05.  
Results 
One SHR and five WKY rats were excluded from analysis because they spent less than 
350 s on one compartment during pre-test sessions. An independent t-test conducted on pre-test 
data revealed a significant strain effect in time spent in the Drug Paired (i.e., non-preferred) 
compartment (t (42) = 3.181, p = 0.003) with WKYs spending significantly less time on the Drug 
Paired compartment than SHRs.  
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Conditioned place preference 
Dunnett’s multiple comparisons test indicated that SHR rats in the 0.6 mg/kg group had 
significantly greater difference scores than SHRs receiving saline (p = 0.036) (See Figure 14).  
Dunnett’s test did not detect any significant differences between saline and any nicotine dose 
groups for WKY rats (all p’s > 0.05).  
 
Figure 14. Mean difference scores across SHR (top panel) and WKY (bottom panel) nicotine 
dose groups. Error bars represent SEM.  The asterisk (*) indicates difference scores were 
significantly greater than the Saline group (p < 0.05) 
 
  An independent t-test revealed that SHRs had significantly more pre-test beam breaks 
than WKYs (t (85) = 3.48, p < 0.001). This pre-test strain difference in locomotor activity 
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prompted separate analyses for SHR and WKY rats to increase the odds of detecting strain-
specific nicotine effects.  
Beam breaks 
A 2 (Compartment) x 2 (Day) x 4 (Dose) ANOVA conducted on SHR beam breaks 
revealed a significant Compartment x Day x Dose interaction effect (F (3,39) = 2.997, p = 0.042) 
(see Figure 15). Follow-up 2 (Compartment) x 4 (Dose) ANOVAs conducted on each 
conditioning day revealed that SHRs made significantly more beam breaks in the Drug Paired 
compartment than in the No Drug compartment across Days 1(F (1,39) = 12.966, p = .001) and 2  
(F (1,39) = 8.586, p = .006). 
 
Figure 15. Mean beam breaks for SHR nicotine dose groups on the Drug Paired Side (left panel) 
and the No Drug Side (right panel). Error bars represent SEM. # denotes a significant effect of 
CS compartment. * denotes a significant effect of conditioning trial. 
 
Follow-up 2 (Day) x 2 (Compartment) ANOVAs conducted at each dose level revealed a 
significant main effect of Day for SHRs receiving the 0.1 mg/kg (F (1,10) = 18.609, p = .002) 
and 0.3 mg/kg (F (1,10) = 6.339, p = .031) doses, with more beam breaks on Day 2 than Day 1 
(0.1 mg/kg: p = .002; 0.3 mg/kg: p = .031). For SHRs receiving the 0.6 mg/kg dose, there was a 
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significant main effect of Compartment (F (1,9) = 5.634, p = .042) and Day (F (1,9) = 13.534, p 
= .005). Pairwise comparisons showed that SHRs in the 0.6 group had significantly more beam 
breaks in the Drug Paired compartment (p = .042) and on Day 2 (p = .005).  
Follow-up 2 (Day) x 4 (Dose) ANOVAs conducted for each compartment revealed a 
significant Day x Dose interaction (F (3,39) = 3.626, p = .021) for the Drug Paired compartment. 
Paired samples t-tests comparing Drug Paired compartment beam breaks between Day1 and Day 
2 at each dose revealed that SHRs receiving saline showed no difference across days (t (10) = 
.357, p = .729). However, Drug Paired compartment beam breaks increased significantly from 
Day 1 to Day 2 for SHRs receiving the 0.1 mg/kg (t (10) = 2.620, p = .026), 0.3 mg/kg (t (10) = 
2.427, p = .036) and 0.6 mg/kg (t (9) = 4.473, p = .002) nicotine doses.  
The ANOVA conducted on No Drug compartment trials revealed a significant main 
effect of Day (F (1,39) = 18.768, p < .001) with significantly more beam breaks occurring in the 
No Drug compartment on Day 2 than on Day 1 (p<.001).  
 
Figure 16. Mean beam breaks for WKY nicotine groups  for the Drug Paired Side (left panel) 
and No Drug Side (right panel). Error bars represent SEM. * denotes a significant effect of 
conditioning trial. 
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A 2 (Compartment) x 2 (Day) x 4 (Dose) ANOVA conducted on WKY beam breaks 
revealed a significant main effect of Day (F (1,39) = 5.941, p = 0.019) with more beam beaks 
occurring on the second conditioning trial than the first (p = .019) (see Figure 16).  
Discussion 
The primary purpose of the present study was to examine sensitivity to nicotine an 
adolescent model of ADHD, the SHR.  The present study tested responsiveness to two properties 
of nicotine: its incentive properties and its capacity to induce locomotion. SHRs developed 
nicotine CPP to the highest dose tested (0.6 mg/kg) while WKYs, the control strain, did not 
develop CPP to any dose tested, an effect that might be due to pre-test compartment biases. 
SHRs were also differentially responsive to nicotine-induced increases in locomotor activity, 
particularly on the second conditioning trial in the Drug Paired compartment, and at the 0.6 
mg/kg dose. These findings complement recent investigations showing that adolescent SHR rats 
respond more for intravenously self-administered nicotine than 10 other strains, including 
adolescent WKY rats (Chen et al., 2012), and collectively support the use of the SHR in studying 
ADHD-related tobacco use.  
WKY rats are the most commonly used and are considered the most appropriate control 
strain for SHRs (Sagvolden & Johansen, 2012).  However, in the present study, significant pre-
test strain differences in locomotor activity and compartment bias prevented direct comparisons 
between strains to be made. Difference scores, our primary measure of CPP, are directly affected 
by pre-test compartment biases. For instance, SHRs and WKYs that received saline spent nearly 
the same amount of time in the Drug Paired compartment during post-test (582 s and 589 s, 
respectively), yet WKY difference scores were 2.5 times greater than SHR difference scores, an 
effect likely caused by differences in pre-test time spent in the Drug Paired compartment 
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between strains. WKYs in the nicotine groups also demonstrated a pre-test compartment bias, 
which interfered with the interpretation of results by reducing confidence that increases in time 
spent in the Drug Paired compartment were drug-induced and not due to a regression-to-the-
mean effect. Because the SHRs showed a lower pre-test compartment bias, regression-to-the-
mean interpretations were less of a concern for this strain. WKYs that received the lowest 
nicotine dose (0.1 mg/kg) had the largest difference scores and spent the most time in the Drug 
Paired compartment during post-test of any group tested. Although this evidence suggests that 
WKYs are sensitive to the incentive properties of a low nicotine dose, difference scores were not 
significantly greater than those produced by saline. This effect is consistent with previous 
investigations showing WKY rats do not develop nicotine CPP (Rauhut, Zentner, Mardekian, & 
Tanenbaum, 2008). 
Consistent with previous investigations, adolescent SHRs were significantly more 
hyperactive than WKYs (Hsieh & Yang, 2008). SHRs were also differentially sensitive to 
nicotine’s locomotor stimulatory properties. During conditioning SHRs receiving the highest 
nicotine dose (0.6 mg/kg) were more active in the Drug Paired compartment following nicotine 
injections than in the saline-paired No Drug compartment. Between conditioning days 1 and 2, 
generalized locomotion (in both Drug Paired and No Drug compartments) increased significantly 
for both strains, however, for SHRs this was selective to rats exposed to nicotine. Because the 
effect of conditioning day on locomotion wasn’t specific to the Drug Paired compartment or to 
the WKY rats that were exposed to nicotine, the change in WKY locomotion across days appears 
to reflect acclimation to conditioning contexts. In contrast, the selective effect of conditioning 
day on nicotine-exposed SHR rats suggests the strengthening of a nicotine-context association 
that may have partially generalized across contexts. 
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In conclusion, despite replicating strain effects in the locomotor behavior of adolescent 
rats and demonstrating that SHRs are differentially responsive to nicotine-induced locomotion, 
we believe that further studies are needed to determine whether SHRs are more sensitive to 
nicotine reward than WKYs. We showed that SHRs develop CPP to a moderately high dose of 
nicotine, but it is likely that the conditioned incentive properties of nicotine were obscured for 
WKYs by a pseudo-conditioning to saline.  
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CHAPTER	  5	  THE	  EFFECTS	  OF	  NICOTINE	  ON	  LOCOMOTOR	  ACTIVITY	  IN	  AN	  ADULT	  ANIMAL	  MODEL	  OF	  ATTENTION	  DEFICIT/HYPERACTIVITY	  DISORDER	  (ADHD)	  
Attention deficit-hyperactivity disorder (ADHD) is a childhood neurodevelopmental 
disorder characterized by symptoms of inattention, hyperactivity and impulsivity (American 
Psychiatric Association, 2013b) that often persist into adulthood (Döpfner, Hautmann, Görtz-
Dorten, Klasen, & Ravens-Sieberer, 2014; Faraone et al., 2005; Kessler et al., 2014). ADHD is a 
risk factor for smoking and tobacco dependence (Glass & Flory, 2010; Kollins, McClernon, & 
Fuemmeler, 2005; Matthies et al., 2013). Adolescents with ADHD begin experimenting with 
tobacco and progress to regular use at a younger age than their non-diagnosed peers and are more 
likely to continue smoking as adults (Breyer et al., 2014; Chang et al., 2012; Lambert & 
Hartsough, 1998). Prevalence of smoking among adolescents and adults with ADHD is double 
that of the general population (Breyer et al., 2014; Lambert & Hartsough, 1998). In addition, 
ADHD smokers consume more cigarettes per day and are rated as more tobacco dependent than 
non-ADHD smokers (Ohlmeier et al., 2007; Wilens et al., 2008). Once dependent, ADHD 
smokers report more frequent and fewer successful quit attempts than non-ADHD smokers and 
exhibit more severe withdrawal symptoms (Humfleet et al., 2005; Kollins et al., 2005; Lasser, 
2000; Pomerleau et al., 1995).   
Motivation to smoke also differentiates smokers with and without ADHD (Mitchell et al., 
2014; Van Voorhees et al., 2012). Specifically, compared to non-ADHD smokers, ADHD 
smokers report that smoking is more positively and negatively reinforcing, leads to greater 
wakefulness and cognitive enhancement, and more effectively decreases irritability and improves 
mood (Van Voorhees et al., 2012). ADHD smokers also report that cigarette puffs are more 
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satisfying and better “liked” than non-ADHD smokers (Van Voorhees et al., 2012). Collectively, 
these findings suggest a greater overall behavioral responsiveness to tobacco use in ADHD 
smokers.   
Understanding the mechanisms underlying an ADHD-related heightened sensitivity to 
the behavioral effects of tobacco relies on the use of pre-clinical methods. Behavioral 
responsiveness to nicotine, the primary psychoactive component of tobacco, can be assessed pre-
clinically in animal models by measuring locomotor sensitization in which repeated nicotine 
exposure leads to an escalation in locomotor behavior following a subsequent nicotine challenge 
injection (Hamilton, Starosciak, Chwa, & Grunberg, 2012; Samaha, Yau, Yang, & Robinson, 
2005). The goal of the present study was to examine nicotine-induced locomotor sensitization in 
the most widely used animal model of ADHD, the spontaneously hypertensive rat (SHR)(Russell 
et al., 2005; Sagvolden & Johansen, 2012), in order to determine if it models the heightened 
sensitivity to nicotine observed in humans with ADHD.   
Baseline differences in locomotor activity between SHR and control strains impose a 
significant challenge in assessing differences in nicotine-induced locomotor sensitization among 
strains. Wistar Kyoto (WKY) rats are the most commonly used control strain for the SHR 
(Russell, 2011; Sagvolden et al., 2009). Multiple studies have shown that basal locomotor 
activity is significantly greater in SHRs relative to WKY controls (Hsieh & Yang, 2008; 
Sagvolden et al., 1992; van den Bergh et al., 2006). Potential differences in nicotine-induced 
locomotor effects between SHR and WKY rats are confounded by preexisting strain differences. 
Therefore, measuring nicotine-induced locomotor sensitization in SHRs and WKYs relies on 
methods that equate baseline locomotion across strains.  
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Experiment 1: Horizontal Locomotion in the Open Field 
Method 
Subjects 
Twelve adult male spontaneously hypertensive rats (SHR; Charles River) and twelve 
male Wistar Kyoto (WKY; Harlan) rats served as subjects. All rats had previous experimental 
history with a variable interval (VI) schedule of reinforcement. All subjects were pair-housed in 
a colony room with a 12:12-h light:dark cycle, with lights on at 1900 h. Experimentation began 
on post-natal day (PND) 123 and was conducted during the night phase of the light:dark cycle. 
Food and water were provided ad libitum in the homecage throughout experimentation. Prior to 
the start of experimentation rats were food restricted and provided 1 hr daily access of food in 
the homecage; during this time water was available ad libitum. All experimental protocols were 
conducted in accordance with the guidelines provided by the National Institute of Health and 
approved by the Arizona State University Institutional Animal Care and Use Committee. 
Apparatus 
The open field arena was a black plastic box with an open top measuring 90x90x40 cm. 
The room was dimly lit, with the arena illuminated by a single shielded white light bulb 
suspended 90 cm above the center of the arena. The arena was further subdivided into two zones 
of interest. The center zone was defined as a 54x54 cm square in the center of the arena; the 
remaining area of the arena was defined as the perimeter. 
Procedure 
Behavioral testing was conducted in three consecutive daily 10-min sessions during 
which rats were permitted to freely move about the open field apparatus. Deionized water was 
used to thoroughly clean the apparatus between subjects. Video tracking software (EthoVision 
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XT 8.1, Noldus Information Technology, Wageningen, Netherlands) recorded the position of the 
animal and horizontal distance traveled five times per second.   
Data Analysis  
The total time spent in the center of the open field apparatus and the total distance 
traveled was calculated daily for each rat and served as the dependent measures. Two 2 (Strain) x 
3 (Day) mixed ANOVAs compared center times and distances traveled between strains and 
among test days. When sphericity was violated, a Huyn-Feldt correction was implemented. Only 
significant effects are reported. 
Results 
Distance Traveled 
Figue 17 shows the mean (+/-SEM) distance traveled in the open field by each strain in 
each test day. ANOVA revealed a significant main effect of Day (F (1.419, 29.793) = 29.859,p < 
0.001). Distance traveled was lowest on Day 1, increased significantly on Day 2 (p < 0.001) and 
then decreased significantly on Day 3 (p = 0.005). The ANOVA also revealed a significant effect 
of Strain (F (1,21) = 52.697, p < 0.001) with SHRs traveling significantly greater distance than 
WKYs (p < 0.001).  
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Center Time 
Figure 18 shows the mean (+/-SEM) time spent in the center of the open field by each 
strain in each test day. ANOVA revealed a significant Strain x Day interaction effect (F (2,42) = 
4.993, p = 0.011).  Independent t-tests comparing center time between strains on each day 
revealed that SHRs spent significantly more time in the center than WKYs on all three days (t 
values ≥ 4.378, all p values < 0.001); this difference appears to be particularly pronounced on the 
second and third test days.  
Figure 17.  Mean (+/-SEM) total distance travelled by SHRs (filled triangles) and WKYs 
(open circles) in an open field, across the test days. SHRs travelled longer distances than 
WKYs. % Significant main effect of Day. # Significant main effect of Strain. 
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Discussion 
The results from Experiment 1 replicate previous reports of SHRs exhibiting greater 
levels of activity in the Open Field task (Hsieh & Yang, 2008; van den Bergh et al., 2006) and 
spending more time in the center of the apparatus (Hsieh & Yang, 2008) than WKYs. Time spent 
in the perimeter of the Open Field apparatus is often used as an index of anxiety (Will, Aird, & 
Redei, 2003); consequently, the present findings suggest higher levels of anxiety in WKYs 
relative to SHRs.  The strain differences in locomotor activity in the present study, and the 
potential interference by anxiety-related processes, make the Open Field task not ideal for 
examining strain differences in nicotine-induced locomotor sensitization. Therefore, locomotor 
activity was assessed in Experiment 2 using a novel method (Rotorat) in order to determine if 
this approach minimizes baseline strain differences in locomotion.  
 
Figure 18.  Mean (+/-SEM) time spent in the center of the open field by SHRs (filled 
triangles) and WKYs (open circles) across test days. SHRs spent more time in the center of 
the open field than WKYs. & Significant Day x Strain interaction. # Significantly greater 
Center Time for SHRs than WKYs 
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Experiment 2: Rotational Behavior in the Rotorat 
Method 
Subjects 
Twenty-four spontaneously hypertensive rats (SHR/NCrl) and 16 Wistar Kyoto rats 
(WKY/NHsd) served as subjects. All rats had previous experimental history with a variable 
interval (VI) schedule of reinforcement. All subjects were pair-housed in a colony room with a 
12:12-h light:dark cycle, with lights on at 1900 h. Experimentation began on post-natal day 
(PND) 99 and was conducted during the night phase of the light:dark cycle. During 
experimentation food and water were provided ad libitum in the homecage. All experimental 
protocols were conducted in accordance with the guidelines provided by the National Institute of 
Health and approved by the Arizona State University Institutional Animal Care and Use 
Committee.  
Drugs 
Nicotine hydrochloride tartrate (NIC; Sigma, St. Louis, MO, USA) and mecamylamine 
hydrochloride (MEC; Sigma, St. Louis, MO, USA) were dissolved in saline (0.9% NaCl). NIC 
solution was adjusted to a pH of 7.2. Both drugs and saline (SAL) were administered 
subcutaneously (s.c.) in a volume of 1 ml/kg. NIC doses were calculated as the freebase weight.  
Apparatus 
Locomotor activity was assessed and recorded using the Rotorat System version 1.2 
(Med Associates, Mt. St Albans, VT). Rats were placed into stainless steel Rotorat bowls (40.6 
cm diameter x 25.4 cm height; model ENV-500, Med Associates) surrounded by clear Plexiglass 
walls. Rats were connected to a spring tether secured to the top of the apparatus by a rotational 
sensor that recorded activity. A zip-tie collar was placed around the neck of the rat and 
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connected to the spring tether via a stainless steel alligator clip. Full (360°) rotations, 90° 
rotations, and direction changes were recorded.  
Locomotor testing procedure 
Table 1 
 
 Timeline depicting dosing schedule across phases for each treatment group.  
 
 PND 99 PND 100 PND 101 PND 102-108 PND 111 
Group Acclimation Acclimation Baseline Chronic NIC Sensitization 
Test 
WKY-SAL 
N = 8 
No Injection SAL SAL SAL:SAL SAL:NIC 
WKY-NIC 
N=8 
No Injection SAL SAL SAL:NIC SAL:NIC 
SHR-SAL 
N=7 
No Injection SAL SAL SAL:SAL SAL:NIC 
SHR-NIC 
N=8 
No Injection SAL SAL SAL:NIC SAL:NIC 
SHR-MEC 
N=8 
No Injection SAL SAL MEC:NIC MEC:NIC 
Note: Cells within each column indicate the drug administered to rats in each phase. Each 
column is labeled with the corresponding phase and age of the rats during that phase. Cells with 
two drugs separated with a colon refer to the pretreatment drug administered 20 min prior to 
testing (to the left of the colon) and the drug administered immediately prior to testing (to the 
right of the colon). During the Chronic NIC phase the nicotine dose administered to WKY NIC, 
SHR NIC and SHR MEC was 0.6 mg/kg, s.c. On Sensitization Test day all rats received a 
nicotine dose of 0.3 mg/kg, s.c.  
 
A timeline describing group assignments is outlined in Table 1. All daily sessions were 
30-min long. On the first day of acclimation they were placed in the Rotorat bowls but were not 
connected to the spring tether. On the second day of acclimation rats were injected with SAL 
(s.c.) immediately prior to testing and were connected to the spring tether. Baseline locomotor 
activity was assessed on the first day following acclimation. During the 7-day chronic nicotine 
phase, rats received either a SAL or MEC pre-treatment injection; 20 min later they received 
either SAL or NIC (0.6 mg/kg, s.c.) and were immediately placed in the Rotorat bowl. Rats were 
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randomly assigned to each treatment group. No testing was conducted and no injections given 
for two days following the last day of chronic nicotine. Then all rats were given a sensitization 
test, in which they were injected with 0.3 mg/kg NIC, s.c., immediately prior to testing.   
Mecamylamine 
Mecamylamine, a non-selective nicotinic receptor antagonist, served as a pre-treatment to 
verify the cholinergic dependency of NIC-induced locomotor sensitization in SHR. A third SHR 
treatment group (n= 7) was included that received a pre-treatment of MEC 20 min prior to NIC 
injections during the chronic nicotine phase. 
Data Analysis  
An independent t-test was used to compare Baseline Full rotations, 90° rotations, and 
direction changes between SHRs and WKYs. Significant Baseline strain differences on a 
dependent variable precluded further analysis of that variable. Dependent variables that did not 
vary significantly in Baseline were further analyzed, each separately. Specifically, Baseline data 
was subtracted from Day 1, Day 7, and Sensitization Test data, resulting in difference scores on 
each phase. Transformed dependent variables were analyzed using mixed ANOVAs to examine 
the acute, chronic, and sensitization effects of NIC on rotational behavior. A 2 (Strain: SHR vs. 
WKY) x 2 (Drug: NIC vs. SAL) ANOVA tested for strain differences in the effects of acute 
NIC. A second 2 (Strain) x 2 (Drug) ANOVA tested for strain differences in the effects of 
chronic NIC. A 2 (Strain) x 2 (Drug) ANOVA tested for strain differences in nicotine-induced 
locomotor sensitization. For SHRs, data from the MEC group was compared to SAL and NIC 
groups by using a one-way ANOVA to assess whether MEC blocked the effects of acute, chronic 
and sensitized NIC on locomotion. Following significant ANOVA results, Tukey’s HSD post 
67	  
hoc test was used. The significance criterion for all analyses was set at .05. With the exception of 
Baseline comparisons, only significant effects are reported. 
Results 
Baseline Differences in Dependent Variables 
Figure 19 shows three dependent variables at Baseline: full rotations, 90° rotations, and 
direction changes. SHR produced significantly fewer full rotations than WKY (t(30) = 6.13, p < 
.001); this variable was, therefore, not further analyzed. No significant strain differences in 90-
degree rotations and direction changes were observed at Baseline (t(30) = 0.88, p = 0.517; t(30) 
= 0.99, p = 0.328, respectively). These two variables are further analyzed separately for nicotinic 
effects. 
 
Figure 19.  Mean (+/-SEM) Baseline full rotations (A), 90° rotations (B) and direction 
changes (C) for SHR (filled bars) and WKY (open bars). At Baseline WKY made significantly 
more full rotations than WKY. # Significant main effect of strain. 
 
90° Rotations 
Ninety-degree rotation difference scores for SHR and WKY under SAL and NIC are 
shown in Figure 20. ANOVA conducted on these scores in Day 1 revealed a significant Strain x 
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Drug interaction effect (F (1,28) = 7.07, p = .013) on 90° rotations. Follow-up t-tests revealed 
that nicotine on Day 1 reduced 90° rotations in WKY relative to saline-treated WKY (t (14) = 
5.82, p < .001) and nicotine-treated SHR (t(14) = 2.21, p = .044). Taken together, these findings 
suggest a stronger suppression of rotational behavior induced by acute NIC in WKYs than in 
SHRs.  
The ANOVA conducted on difference scores in Day 7 revealed a significant Strain x 
Drug interaction effect (F (1,28) = 6.07, p = .020) on 90° rotations. Follow-up t-tests revealed 
that nicotine on Day 7 reduced 90° rotations in WKY relative to saline-treated WKY (t(14) = 
4.13, p = .001) and nicotine-treated SHR (t(14) = 2.91, p = .011). Taken together, these findings 
suggest that the strain-specific nicotine-induced suppression of rotational behavior observed in 
Day 1 persisted to Day 7. 
The ANOVA conducted on difference scores in the Sensitization Test revealed 
significant main effects of Drug (F (1,28) = 14.16, p = .001) and Strain (F(1,28) = 6.49, p = .017) 
on 90° rotations. The test dose of nicotine induced larger increases in 90° rotations in SHRs than 
WKYs and in NIC-treated than SAL-treated rats. Taken together, these findings suggest that 
nicotine more effectively increased 90° rotations in rats with a previous NIC history, regardless 
of strain.  
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Figure 20. Mean (+/-SEM) difference in 90° rotations between Baseline and Day 1, Day 7 and 
sensitization test for SHR (filled symbols) and WKY (open symbols) under nicotine (squares) 
and saline (circles) treatments. Acute (Day 1) and chronic (Day 7) nicotine suppressed 90° 
rotations in WKY. Nicotine-induced rotational behavior was sensitized in both strains.  
*Significant main effect of drug. # Significant main effect of strain. & Significant Strain x Drug 
interaction effect.  
 
 
Direction Changes 
Direction-change difference scores for SHR and WKY under SAL and NIC are shown in 
Figure 21. The ANOVA conducted on these scores in Day 1 revealed a significant main effect of 
Drug (F (1,28) = 34.42, p < .001) on direction changes; NIC reduced the frequency of direction 
changes.  
The ANOVA conducted on the difference scores in Day 7 revealed significant main 
effects of Drug (F (1,28) = 20.02, p < .001) and Strain (F(1,28) = 11. 58, p = .002). On Day 7, 
direction changes increased more in SHRs than in WKYs, and in nicotine-treated rats more than 
in saline-treated rats.  
The ANOVA conducted on the difference scores in the Sensitization Test revealed 
significant main effects of Drug (F (1,28) = 13.66, p = .001) and Strain (F(1,28) = 14.59, p = 
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.001). On the Sensitization Test, direction changes increased more in SHRs than in WKYs, and 
in nicotine-treated rats more than in saline-treated rats.  
 
Figure 21. The mean (+/-SEM) difference in direction changes from Baseline across Day 1, Day 
7 and Sensitization test for SHR  (filled symbols) and WKY (open symbols) NIC (squares) and 
SAL (circles) groups. Acute (Day 1) and Chronic (Day 7) nicotine suppressed direction changes 
in both strains. Nicotine-induced direction changes was sensitized in both strains. * Significant 
main effect of drug. # Significant main effect of strain.  
 
Mecamylamine 
SHR: 90° Rotations 
Ninety-degree rotation difference scores for SHR under SAL, NIC, and NIC pretreated 
with MEC are shown in Figure 22. A significant effect of Treatment was detected on 
Sensitization-Test performance (F (2,20) = 5.70,p = .011). The test dose of nicotine induced a 
larger increase in 90° rotations in SHR-NIC group than in SHR-SAL (p= .010) and SHR-MEC 
(p = .008) groups. No significant effect of Treatment was detected on Days 1 (F (2,20) = 1.04, p 
= .370) or 7 (F (2,20) = 0.35, p = .703). These results indicate that MEC effectively blocked the 
sensitizing effect of nicotine on rotational behavior.   
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SHR: Direction Changes 
Direction-change difference scores for SHR under SAL, NIC, and NIC pretreated with 
MEC are shown in Figure 23. A significant effect of Treatment was detected during Day 1 (F 
(2,20) = 3.74, p = .041) and Sensitization Test (F (2,20) = 5.59,p = .012) on direction changes, 
but not during Day 7 (F (2,20) = 1.23, p = .311). On Day 1, NIC reduced the number of direction 
changes in SHRs relative to SAL-treated SHRs (p = .018), but not reliably relative to MEC-
pretreated SHRs (p = .051). On the Sensitization Test, NIC increased the number of direction 
changes in SHRs relative to SAL-treated (p = .014) and MEC-pretreated SHR (p = .006) groups. 
These results indicate that MEC effectively blocked the sensitizing effect of nicotine on the 
number of direction changes.  
Figure 22. Mean (+/- SEM) differences in 90° rotations from Baseline across Day 1, 
Day 7 and Sensitization test for SHRs in the saline-nicotine (SHR-SAL; squares), 
saline-saline (SHR-SAL; circles) and mecamylamine-nicotine (SHR-MEC; 
downward triangles) Treatment groups.  Mecamylamine blocked the sensitizing 
effect of nicotine on rotational behavior. * Significant main effect of Treatment.  
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Discussion 
The purpose of the present experiments was to (1) replicate previous reports of 
differences in SHR and WKY locomotor activity in the Open Field task (van den Bergh et al., 
2006; Will et al., 2003), (2) determine whether differences in locomotion between SHR and 
WKY strains could be reduced using a novel approach (Rotorat), and (3) compare nicotine-
induced locomotor sensitization in SHR and WKY rats. Results from Experiment 1 replicated 
previous reports showing that SHRs are more active than WKYs in an Open Field apparatus (van 
den Bergh et al., 2006; Will et al., 2003). Specifically, SHRs spent a greater amount of time in 
the center of the open field apparatus and had greater overall locomotor activity relative to 
WKYs. However, in the Experiment 2, SHRs did not exhibit greater baseline levels of 90° 
rotations and direction changes in the Rotorat. These results suggest that locomotor differences 
Figure 23. Mean (+/- SEM) differences in direction changes from Baseline across Day 1, Day 7 
and Sensitization test for SHRs in the saline-nicotine (SHR-SAL; squares), saline-saline (SHR-
SAL; circles) and mecamylamine-nicotine (SHR-MEC; downward triangles) Treatment groups.  
Mecamylamine blocked the sensitizing effect of nicotine on rotational behavior. * Significant 
main effect of Treatment. 
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between SHRs and WKYs depend on the apparatus used and the type of locomotor behavior it 
engenders.   
It is possible that the strain differences observed in the Open Field are more accurately 
described as WKY hypoactivity rather than as SHR hyperactivity (van den Bergh et al., 2006). 
WKYs are commonly used to model anxiety-like behavior (Will et al., 2003). Unlike the Open 
Field apparatus, the Rotorat bowl does not appear to elicit anxiety-like locomotor suppression in 
WKYs and was therefore chosen instead of the Open Field apparatus to examine the differential 
effects of nicotine on the locomotor activity of SHR and WKY. 
Results from Experiment 2 showed that SHRs are less sensitive than WKY to nicotine’s 
locomotor depressant effects. Nicotine initially depressed 90° rotations and direction changes in 
both strains, but to a larger extent in WKYs. Locomotor depression following the initial nicotine 
administration is common in adult rats (Clarke & Kumar, 1983b; DiFranza & Wellman, 2007; 
Ksir, 1994; Morrison & Stephenson, 1972), however, tolerance to this effect typically develops 
following additional presentations (Clarke & Kumar, 1983b; DiFranza & Wellman, 2007). 
Tolerance to nicotine’s depressant effects commonly precedes onset of sensitization to nicotine’s 
stimulant effects which are typically observed following repeated exposure (Clarke & Kumar, 
1983b; DiFranza & Wellman, 2007). The results from Experiment 2 are not consistent with this 
pattern of nicotine effects. The initial depressant effects of nicotine, which typically rebound by 
the second daily administration, was still visible in WKYs after 7 daily administrations; by the 
end of this phase, SHR locomotion was similar across Treatment groups. These findings suggest 
that nicotine-induced locomotor suppression in adult SHR and WKY is particularly long lasting; 
future research comparing these strains against outbred strains may verify this hypothesis. In any 
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case, the present study shows that the depressant effects of nicotine on locomotion animal model 
of ADHD (SHR) are relatively brief, compared to a control strain (WKY). 
A chronic regimen of nicotine led to a sensitized locomotor response in both strains to a 
low-dose (0.3 mg/kg) challenge injection. Although nicotine-treated SHR produced more 
locomotor activity than nicotine-treated WKY during the Sensitization Test, the absence of a 
significant Strain x Drug interaction effect on sensitization performance precludes interpreting 
this difference as reflecting a heightened sensitization in SHR. It is possible, for instance, that the 
strain difference in Sensitization Test performance was carried over from Day 7 of chronic 
administration, even though these assessments were separated by 72 h. 
 Mecamylamine, a central nicotinic receptor antagonist, has been shown to block the 
locomotor effects of nicotine (Clarke & Kumar, 1983b; Kempsill & Pratt, 2000b). In Experiment 
2, SHRs that received a mecamylamine pretreatment prior to nicotine were not sensitive to 
nicotine’s depressant or stimulant effects. These results suggest that nicotine’s depressant and 
stimulant effects in SHR and WKY are mediated by central nAChRs. 
Conclusion 
 The present study replicated previous findings showing greater SHR locomotor activity 
compared to WKY controls in the Open Field task (Hsieh & Yang, 2008;  Sagvolden et al., 1992; 
van den Bergh et al., 2006). It also provided evidence that a novel method (Rotorat) yields 
measures of locomotor activity in which strain differences were minimized. Results from 
Experiment 2 demonstrated that adult SHRs are less sensitive to nicotine’s locomotor depressant 
effects than adult WKYs, and that these effects are mediated by central nAChRs. To the extent 
that locomotion suppression reflects the aversive properties of nicotine (Bevins & Palmatier, 
2003; Laviolette & van der Kooy, 2003), these results suggest that SHR are less responsive to 
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these aversive properties. Thus, this experiment suggests that smoking among adults with ADHD 
may persist at high rates, in part, because they experience fewer aversive effects of nicotine than 
adults without ADHD. Such hypothesis is consistent with differences in the subjective 
experience of smoking reported by individuals with and without ADHD (Van Voorhees et al. 
2012). Adult SHRs, relative to WKYs, appear to accurately model this differential experience. 
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CHAPTER	  6	  GENERAL	  DISCUSSION	  
This dissertation contains a series of experiments designed with two primary goals. The 
first goal was to evaluate the fixed minimum interval (FMI) schedule as a method for assessing 
response inhibition capacity (RIC) that is 1) robust against motivational manipulations, and 2) 
capable of detecting RIC deficits in an animal model of ADHD, the spontaneously hypertensive 
rat (SHR). The second goal of this dissertation was to assess the sensitivity of the SHR to the 
rewarding and locomotor properties of nicotine.   
The FMI schedule as a method for assessing RIC 
Chapter 2 examined the robustness of FMI-derived estimates of RIC against transient and 
prolonged changes in motivation. It showed that latencies were more sensitive to pre-feeding 
than estimates of θ. Specifically, pre-feeding significantly affects three of the four FMI schedules 
tested, whereas only estimates of θ from the FMI 3-s schedule were significantly affected. It also 
showed that changes to the rate and magnitude of reinforcement significantly affects latencies, 
but not θ, demonstrating that these manipulations to reinforcer efficacy differentially alter 
motivation to respond for reinforcement, and not the ability to withhold premature responses. 
Collectively, results from Chapter 2 support and extend those of Mechner and Guevrekian 
(1962), who originally described the FMI schedule and showed that latencies to the initial 
response, and not inter-response times, were sensitive to level of reinforcer deprivation. Notably, 
changes to deprivation levels and reinforcer magnitude have been shown to affect estimates of 
RIC in alternative response-withholding tasks such as the differential reinforcement of low rate 
(DRL) schedule (Doughty and Richards, 2002; Kirshenbaum et al., 2008). The discrepancy 
between the current results and those derived from other response-withholding tasks is due to the 
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ability of the FMI to effectively dissociate incentive-motivational effects from inhibitory effects, 
which are confounded in tasks like the DRL. Pre-feeding has also been shown to significantly 
affect measures of response inhibition in the 5-CSRTT (Bizarro & Stolerman, 2003; Grottick & 
Higgins, 2002). Because of its ability to dissociate inhibitory and incentive-motivational effects, 
the FMI task may be preferred to the DRL and 5-CSRTT for future studies in which the effects 
of changes in motivation is of primary interest.  
One drawback to the FMI, as shown in Chapter 3, is that it does not differentiate between 
SHRs and a control strain on measures of RIC. Specifically, Chapter 3 showed that SHRs and 
WKY controls had comparable θ estimates.  This is consistent with previous reports from our 
laboratory (Mazur et al., 2014) and could either suggest that RIC is not impaired in SHRs or that 
the FMI is not able to detect real RIC deficits in the SHRs. Multiple studies have shown 
differences in RIC in the DRL (Orduna et al., 2009; Sanabria and Killeen, 2008) but not the 5-
CSRTT (van den Bergh et al., 2006). Measures of incentive-motivation and RIC are confounded 
in the DRL; therefore, it is possible that strain differences reflect differences in motivation rather 
than differences in RIC. Results from Chapter 3 showing shorter post-R and post-N latencies in 
SHRs relative to WKYs supports the notion that strain differences observed in the DRL task 
(Sanabria & Killeen, 2008; Orduna et al., 2009) may be partially due to differences in incentive 
motivation.  
Chapter 3 also examined the role of collateral behavior in SHR performance on the FMI.  
Children with ADHD have been shown to engage in more collateral behavior than non-
diagnosed children on the DRL task (Gordon, 1979). Whereas most studies have shown that 
collateral behavior is associated with better DRL performance (Laties et al., 1965, 1969; Stein & 
Landis, 1975). Gordon showed that it is detrimental to performance of children with ADHD. The 
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number of collateral lever presses made during the inter-response time (IRT) were compared 
between SHRs and  WKY controls. Collateral lever presses were comparable between SHR and 
WKY rats, which suggests that, unlike children with ADHD, SHRs do not engage in more 
collateral responses during the waiting interval than controls. However, these results do not 
preclude the possibility that SHRs (and WKYs) engaged in other forms of collateral behavior 
that were not measured. Gordon (1979) reported that only a quarter of the children with ADHD 
engaged in the programmed collateral response (i.e., key presses). Most of the children engaged 
in some other form of overt response that was unique to each child. Future research measuring 
collateral behavior in SHRs would benefit from motion-detection software that captures a wider 
array of locomotor behaviors during the IRT. Another potential reason strain differences in 
collateral lever presses were not observed is that the 4.5-s criterial waiting time was not long 
enough to sufficiently tax the SHR’s ability to withhold premature responses. It is possible that 
strain differences in collateral behavior emerge only under longer FMI requirements. We have 
previously observed (unpublished observations) that under an FMI 6-s schedule, collateral lever 
presses are positively correlated with the percentage of correct IRTs in SHRs but not WKY rats. 
These observations lend support to the notion that the relationship between collateral behavior 
and FMI performance may be dependent on the schedule in effect.  
Nicotine sensitivity in the SHR 
ADHD is a risk factor for tobacco dependence (Kollins et al. 2005; McClernon & 
Kollins, 2008). Individuals with ADHD begin smoking and progress to regular use at a younger 
age than non-diagnosed peers (Kollins et al., 2005b; Milberger et al., 1997). In addition, 
adolescent ADHD smokers are more likely to become tobacco dependent (Kollins et al., 2005) 
and to continue smoking into adulthood than non-ADHD smokers (Breyer et al., 2014; Chang et 
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al., 2012; Lambert & Hartsough, 1998). We attempted to shed light on the relationship between 
ADHD and smoking by examining the behavioral effects of nicotine, the primary psychoactive 
component in tobacco, in SHRs.  
Chapter 4 examined nicotine’s locomotor and rewarding effects in adolescent SHRs 
using the conditioned place preference (CPP) procedure, a Pavlovian measure of conditioned 
drug reward. SHRs developed nicotine CPP to the highest dose tested (0.6 mg/kg), whereas 
WKYs, the control strain, did not develop CPP to any dose tested. SHRs were also differentially 
responsive to nicotine’s locomotor-enhancing properties.  SHRs were particularly sensitive to 
nicotine’s locomotor-enhancing effects on the second conditioning trial, and at the 0.6 mg/kg 
dose. Nicotine did not affect locomotor activity in WKYs at any dose tested.  These results 
suggest that SHRs are more sensitive to nicotine than WKYs; however, baseline strain 
differences in locomotor activity and compartment bias prevented comparisons between strains. 
Relative to SHRs, WKYs had a significantly greater baseline side bias and significantly lower 
locomotor activity levels. WKYs showed a pseudo-conditioning to saline that was linked to an 
initial side bias, and which obscured any potential conditioned incentive properties of nicotine. It 
is therefore recommended that future research examining nicotine CPP in SHRs choose a control 
strain that is less prone to the baseline biases observed in WKYs.  
The locomotor differences between strains observed in Chapter 4 support previous 
reports of SHR hyperactivity (van den Bergh et al., 2006; Will et al., 2003).  Chapter 5 showed 
that adult SHRs also were more active in the open-field relative to WKYs, which suggests that 
locomotor strain differences persist throughout development. However, when rotational behavior 
in the Rotorat apparatus failed to demonstrate SHR hyperactivity, which indicates that locomotor 
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strain differences depend on the apparatus used and the type of locomotor behavior it engenders 
(i.e., horizontal vs. rotational locomotor behavior).  
Open-field results from Chapter 5 support previous reports that WKYs are hypoactive 
(van den Bergh et al., 2006; Will et al., 2003) and spend more time along the perimeter of  the 
open field rather than in the center, an index of anxiety-like or depressive-like behavior (Will et 
al., 2003). WKYs were not hypoactive in the Rotorat apparatus, an effect that was likely due to 
its bowl-like shape, which minimizes the amount of time WKYs were able to be inactive along 
the perimeter.  Because the Rotorat apparatus minimized WKY hypoactivity, it was used to 
assess nicotine-induced locomotor effects between strains.  
Chapter 5 showed that SHRs are less sensitive than WKYs to nicotine’s locomotor 
depressant effects.  While nicotine initially suppressed 90° rotations and direction changes in 
both strains, SHRs recovered from the suppressive effects by Day 7, whereas WKYs did not. 
Nicotine-treated rats from both strains showed a sensitized response to a low-dose challenge 
injection of nicotine (0.3 mg/kg). Nicotine-treated SHRs had greater locomotor activity during 
the sensitization test than nicotine-treated WKYs, however, this difference might have been 
carried over from the final day of chronic administration. Furthermore, the absence of a 
significant Strain x Drug interaction precludes interpreting this difference as heightened 
sensitization in SHRs. 
There are a number of limitations associated with the methods used in Chapters 4 and 5. 
Specifically, rats received nicotine passively; it has been argued that passive administration 
cannot be generalized to human drug use (Bardo & Bevins, 2000). A second limitation with the 
CPP procedure is that behavior on test day, when the rat is not under the influence of any drugs, 
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may be interpreted as novelty-seeking rather than reflecting drug reward (Bardo & Bevins, 
2000).  
 Future research comparing the sensitizing effects of nicotine between SHRs and WKYs 
would benefit from using a wider array of doses and additional dosing regimens, both of which 
have been shown to affect nicotine-induced locomotor sensitization (Vezina et al., 2007; 
DiFranza and Wellman, 2009). We chose a nicotine dose that is within the range of doses shown 
to most robustly lead to sensitization in rats (Benwell & Balfour, 1992; Clarke & Kumar, 1983; 
DiFranza & Wellman, 2005; Kempsill & Pratt, 2000a; Vezina, McGehee, & Green, 2007); 
however, the persistence of locomotor suppression across seven days of chronic exposure in 
WKYs suggests that this dose may have been too high for this strain.  The dosing regimen we 
chose also induces sensitization in outbred rats (Benwell & Balfour, 1992); however, because 
WKYs did not develop tolerance to nicotine’s locomotor-suppressive effect, it possible that this 
regimen was not optimal for WKYs.    
Collectively, results from Chapters 4 and 5 reveal that SHRs are sensitive to the 
rewarding and locomotor-enhancing properties of nicotine, both of which are likely mediated by 
the mesolimbic dopamine system (Kempsill & Pratt, 2000; Benwell & Balfour, 1992; Clarke & 
Kumar, 1983). However, demonstrating SHRs are a suitable model of ADHD-related tobacco 
use requires evidence that sensitivity to nicotine is greater in SHRs than controls. Results from 
Chapters 4 and 5 showed that WKYs should not be used as a control for investigating nicotine 
effects on locomotor activity. Therefore, future research aimed at validating the SHR as a model 
for studying ADHD-related tobacco use should use a different control strain to determine 
whether SHRs are more sensitive to nicotine’s rewarding and locomotor enhancing effects.  
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In addition, future research should also examine which aspects of ADHD-related tobacco 
use the SHR models (e.g., more severe withdrawal symptoms). Finally, in addition to assessing 
the sensitivity to nicotine, future research should also evaluate the sensitivity of the SHR to other 
non-nicotine tobacco smoke constituent compounds (Ypsilantis, Politou, Anagnostopoulos, 
Kortsaris, & Simopoulos, 2012). 
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